Summaries of articles for Gerontology from a Psychological Perspective

Summaries of the assigned articles for Gerontology from a Psychological Perspective for the Rijksuniversiteit Groningen in the 3rd study year.

Please note that the summaries also include Module 21 of the NHG-standaarden - Geneeskunde - Thema: Psychische problemen (Dementie), this link can be found under 'Supporting content', please note that this source is in Dutch.

 

Topics that will be discussed: Ag(e)ing, Gerontopsychology, Dementia, Decision-making psychology, Caregiver's burden, Alzheimers

Image

Check summaries and supporting content in full:
Introduction: Older People under the Magnifying Glass - Komp & Aartsen - 2013 - Article

Introduction: Older People under the Magnifying Glass - Komp & Aartsen - 2013 - Article

These days, people are getting older and older. Europe is the oldest continent in the world at this moment. According to research, every sixth European is 65 years or older. Scientists also predict that there will even be more older Europeans in the future. They think that every fourth European will be 65 or older in 2050. This will of course have an impact for all the citizens and societies of Europe. For example, shop owners will include more products for seniors in their assortments and public places will have to make their place more accessible to older and handicapped individuals. The finances of countries may also have change. There will be more people on a pension and so the pension schemes might need to restructure their financial basis. An increase of older people will also mean an increase in the long-term care schemes and these might also have to be changed. This change raises many questions and these questions will be answered by the scientific discipline of gerontology.

Gerontology

Gerontology is a scientific discipline that studies human ageing. The study draws from different scientific disciplines like economy, sociology, psychology, epidemiology and of course, biology. The word has its origin in Greek. ‘Geron’ in Greek means old man and ‘gerh’ means growing up or aging. The word refers to being old and also to the process of ageing. The word ‘gerontology’ was first used in the 19th century, but throughout the history, people have been interested in gerontology.

Usually when people think about old age, they think about grey hair, hearing loss, wrinkles, trouble walking and memory loss. However, old 3age is not just a biological phenomenon, it’s also a social one. It is society that influences how people see themselves, how their lives are structures and what opportunities certain groups have. An example of this is the retirement law. This law states that people around 65-67 need to withdraw from paid work. From this age, people are considered to be old. This biological and social understanding of old age went hand in hand for a long time. People around the age of 65 went in retirement and they also experienced health problems. This changed during the last decades. Some people retired earlier, but they remained healthy until an older age. Today, we don’t see the age of 65 as a marker for both retirement and health problems. Consequently, people ask then when old age starts and what its characteristics are.

There are many gerontological discussions that stress the diversity of old age. Some gerontologists state that people become old when they turn 50, others state that people become old once they reach 75 years. Researchers did find a solution for the differences of opinion and that solution is to see old age as a sequence of two separate and distinct periods of life. These periods are called the young-old age and the old-old age or the third age and the fourth age. The third age is a period in which people have a relative freedom and good health. People in this age period don’t have the responsibility for the upbringing of their children and they also don’t have to work. The fourth age is a period in which there is an accelerated decline of mental and physical health. People in this period have also losses in social relationships. Every understanding of old age has its advantages and disadvantages. Also, the usefulness of the understanding depends on the context.

Europe and old age

Europe is a great continent for the study of old age, because it’s the oldest continent in the world. In Europe scientists can encounter many older people and they can also observe how societies change when populations age. Another positive thing about studying old age in Europe, is that Europe is heterogeneous. This means that there are clear visible differences within Europe in how old people are and how people deal with old age. The differences that exist are not only between countries, but also within countries. This means that scientists need to look into between-country differences as well as within-country differences to understand how old age transforms Europe. Before doing this, one needs to know what dimensions population ageing has reached. A description of Europe’s age-profile is needed and it will be discussed in the next part.

As mentioned before, Europe is older than any other region of the world. Northern America is slightly younger than Europe. The youngest continent in the world is Africa. In 2009, the median age in Europe was 40 years. This was 12 years more than the median age in the rest of the world and 21 years more than the median age in Africa. In that same year, every sixth European was in the 65+ age group, which is 16% of the population. In that same year, every 33th African was in the same age group. In 2009, 4% of Europe’s population was in the 80+ age group, but scientists expect that group to get bigger over the next decades.

Scientists have looked at the progression of population ageing in Europe. They figured out that less than 10%of Europeans were aged 65 years or older in 1950. In 2010, this group grew to 16% of the population. Researchers think that the 65+ group might continue to increase to 27% until 2050. That means that in 2050, every fourth European will be aged 65 years or older. If their predictions are correct, then the number of Europeans in that age group will have more than doubled within a century. Scientists have also looked at the rest of the world and they found out that only 5% of the world population was aged 65 years and older in 1950. In 2010, this group grew out to 8% and researchers think it will grow to 16% by 2050. This means that every sixth person in the world would be 65 years or older by then.

The numbers just mentioned describe Europe in its entity, but the basic information also is true for the individual European countries. All European countries are ageing and in every European country the number of older people will get bigger in the future. However, the level of population ageing reached and the speed at which populations age differs across the countries. North and West Europe were the oldest regions in the 1950s and Eastern and Southern Europe were the youngest ones. Population ageing progressed relatively slowly in Northern Europe and relatively quickly in Southern Europe and because of this, the age-gradient within Europe will probably be shifted by 2050. By 2050, the oldest populations in Europe will be in the South and West and the youngest population will be in the North and East.

In Figure 1.2 of the book ‘Old age in Europe’ on page 5, the median age of the population in the individual European countries in 2010 is shown. There are three different median ages in Europe in this figure, low (35 years of below), intermediate (36-40) or high (41 years and older). Note that figure 1.2 is not correct! The text about that figure is correct! Europe has a couple of countries where the median age is below 35 years. These countries include Turkey, Ireland, Iceland, Moldova and Albania. Some of the intermediate countries are the Netherlands, Germany, Sweden, Portugal and Greece. Some of the countries where the median ages are high include Norway, Spain, Russia, Poland, France and the United Kingdom. Europe is indeed greying, but it is greying in different ways. Countries differ in how fast population aging progresses and in how far it has progressed. Also, when researchers look even deeper, they see that differences also exist within countries, because people within countries do not age homogeneously. Researchers have found some differences between population groups when it comes to how fast population ageing progresses. They found that there are more women than men in the higher age groups and that the population in rural areas ages faster than the population in cities. Factors like migration and local cultures can also cause some of these within-country differences in the population ageing progress.

Characteristics of older Europeans

According to the writers of this text, the older European does not exist. Older Europeans resemble each other to some degree, but there are many differences between them. The variation is to some degree caused by country-characteristics. There are/were many different political constellations in Europe, like the former communistic East and the liberal-democratic West. There are also different religious orientations in Europe, like the mainly catholic South and the mainly protestant North. Variations are also due to differences between the individuals within a country. Individual differences can be caused by gender, marital status, socioeconomic status, living arrangements and religious affiliation. When you take all these possible variations into account, you will see that there is a diverse group of old people in Europe.

One of the biggest differences between older Europeans is their gender. There are about as many women as men in Europe, but this ratio is different in older age groups. There are a bit more women aged 65 years and older in Europe than men. In some countries, this difference is marginal (Iceland and Macedonia), while in others two out of three older people are female (the Ukraine and Latvia). That gender difference results from two factors. The first factor is quite obvious. Women live longer than men do. Because of this, women are over-represented in the older age-groups. The second factor is that mostly men fight as soldiers in wars, so war-related deaths are particularly common among men. Another difference between old Europeans is in their social networks. These are connections with friends and kin. Connections with friends and kin are important for older people, because they enhance their wellbeing and health. Friends and kin are also supportive in times of crisis. These days kinships are looser than in the decades before, but there are differences between countries. In Norway, Sweden and Finland there is extended de-familialization. This means that friends become more important. Also, in these countries and in the Netherlands, the highest levels of memberships of clubs and voluntary work are common. In Eastern Europe and in South Europe, family ties are still very important.

Another big difference between older Europeans is their socio-economic status. The socio-economic status tells us the position a person has in society. This status is determined from wealth, occupation and educational level. The wealth of older Europeans is relatively low in Eastern European countries like Poland and the Ukraine and relatively high in continental European countries, like Belgium and France. The educational level is also higher in Continental Europe and Northern Europe, like Austria and the Netherlands than in Southern Europe, like Spain and Greece. Also, the occupational prestige of older people is higher in Continental and Northern Europe than in Southern Europe.

It seems that in Eastern Europe, the circumstances of aging healthy are the least favourable. In those countries, the level of resources for health care is the lowest and the people from those countries have the highest prevalence of smoking and obesity. By contrast, in Northern and Western Europe, people have the best health care and the lowest level of risk factors for diseases. The highest proportion of obese people in Europe are from Eastern Europe (21%) and the lowest proportion is from Western Europe (18%). Of course, there are variations within the regions. For example, the highest proportion of obese men can be found in the Czech Republic (31%), but the lowest proportion of obese men can also be found in Eastern Europe, in Moldova (10%). Every country has its own progress of aging and in the next section, three countries from Europe will be discussed.

Old people in Italy

After Germany, Italy is the oldest country in Europe. Italy is the third oldest country in the world. Because of this, researchers often look at Italy when they want to know how societies change by aging. They think that studying Italy today will give them information about the things that will happen in other European countries in the next decades. 6% of the Italian population were aged 80+ in the beginning of the 21st century. This is the highest percentage of the European countries. There are a couple of regions in Europe with a high proportion of people aged 80+ living in them and seven of the ten regions can be found in Italy. Italians think, on average, that old age starts at 68 years. This age is one of the highest named in Europe. Old people in Italy have a low level of engagement in productive activities. 37% of Italians aged 55-64 was employed and this is one of the lowest percentages within Europe. Also, older Italians don’t participate a lot in voluntary, political and religious organizations or sports clubs and social clubs. Italians say that this is because the old people want to engage more with their family and they often look after their grandchildren and therefore don’t have much time to do other things. So it’s not that they are less engaged, but they are engaged in a different context than other Europeans.

In Italy, public care services are relatively scarce and it is therefore difficult to organize care provision for older people who need it. The care services also differ across Italy and the family will have to do most of the care work. Italians often hire migrant care workers (called badanti) to support the family carers. Often, the badanti live with the person they are taking care of and they help them with their daily lives. Of course there are certain working- and migration-regulations and the badanti work for a couple of months in Italy and then have to return for several months to their home countries.

Old people in Sweden

Sweden has a great labour market situation for old people. About 70% of Swedish people aged 55-64 worked in a paid job. This is the highest percentage in Europe. Ageing in Sweden has little effect on the pension schemes and labour market. The ageing in Sweden is the European average. However, people in Sweden live longer than averages Europeans do and they also stay healthy until an old age. After reaching the age of 65 years, Swedish people can expect to spend 14 years in good health, on average and then five years in poor health. Swedes perceive old age starting at 67 years. This is relatively late, the European average is 64.

Because of their good health, Swedish old people can be active until a late age. They also tend to do this. Sweden has one of the highest shares of volunteers in the 50 years and older age group. They also are more likely to provide care and health than other older Europeans and because of this, researchers conclude that old people from Sweden are still productive. They engage in different activities to benefit society and their family. However, old Swedish people are less active than most Europeans in religious organizations. The government of Sweden also helps with old people’s productivity by providing health and social services and by providing a good pension scheme. The government also established the right to work until age 67.

Old people in Slovakia

While Italy is one of the oldest countries in Europe, Slovakia is one of the youngest. The median age in 2010 was 37 years. This is 4 years younger than the European average. Slovakia can look to older countries and prepare for what might come when the population ages. In Slovakia, the youthfulness is visible in different ways. People from Slovakia who are 65 years old can expect to live three more years in good health and then 13 years in poor health. This life-expectancy in good health is five years below the European average and eleven years below the one in Sweden. The life-expectancy in Slovakia is also 3 years below the European average. Therefore, you can see older Slovakian less often than in other European countries. Slovakians also have a more youthful understanding of old age than other Europeans. They namely think that old age starts at 58 years. This is six years below the European average and the lowest one named in Europe.

Slovakia has also a distinct living situation. The average Slovakian retired at age 58 in 2009. This is one of the lowest retirement ages in Europe. The mandatory retirement age in Slovakia is 62. Retired Slovakians are less likely to volunteer than other European retired people. The low levels of engagement in work and volunteering might be a result from the early health deterioration in Slovakia. However, older Slovakians are socially integrated despite this low engagement and high health decline. Researchers from Slovakia concluded that social and health care are a central issue in Slovakian old age policies. They also said that the government has been regulating social and health care for older Slovakians throughout the last decades. But they also said that those policies did not always put emphasis on the situation of older Slovakians. Clearly, this has to change.

Access: 
Public
Bio- and Health Gerontology: How Ageing Changes our Bodies - Ankri & Cassou - 2013 - Article

Bio- and Health Gerontology: How Ageing Changes our Bodies - Ankri & Cassou - 2013 - Article

Ageing can be seen as a big process which involves different components. Some of these are biological, social, spiritual, environmental and psychological in nature. The study of these components and their interrelations is gerontology. The sub-discipline of gerontology which focuses on physical processes, is called bio- and health gerontology. Some biologists and biochemists study the process of ageing on a molecular level and they try to figure out how the ageing process affects organs and the entire body. The scientific field of that study is called biogerontology. Some of the questions answered by biogerontologists are why human cells die and how organs stay stable over time. These scientists see biological ageing of the body as the result of the appearance and disappearance of the cells of organs.

Organs have cells that die and that are replaced by new cells. De Grey is a biogerontologist from Great Britain and he studied the free radical theory and the role of mitochondria and concluded that ageing can be seen as a disease. De Grey states that we have more and more knowledge about medicine and that, because of this, we will be able to address ageing just like we address many diseases. However, some gerontologists think that he is being too optimistic. This is because biogerontologists use animals like rats and flies for their studies and it is not clear whether these results can be generalized to humans.

Doctors who do clinical research and epidemiologists (they study populations) are in the field of health gerontology. That field is linked to the environmental and social aspects of human ageing. This field tends to focus on changes in the body as it ages, the consequences of this change for daily living and the use of health care services. Some of the questions with which health gerontologists are concerned with are how one can help people to live longer and how one can increase the healthy life expectancy. Health gerontology looks at social inequalities when trying to answer the questions. This can be between different educational levels or income groups. In this field two levels of health-related intervention are underlined. These levels are the individual level and the population level. The individual level might focus on health promotion and prevention and the population level might focus on housing conditions and organization of social care systems.

Theories and concepts

Although Europeans live longer than ever before, it doesn’t mean that the extra years are healthy ones. Old age often goes together with disease. However, it’s difficult to find where health ends and disease starts. It is difficult, because health can be understood in different ways.

Looking at the traditional definition of health, health is the freedom from disease. When people age, their health deteriorates and people develop diseases. Old age and good health were therefore seen as mutually exclusive states. This opposition can be explained with senescence. Senescence describes biological ageing. Bodies react to changes more slowly with senescence and as a consequence, they recover from illnesses with more difficulty. Because of this, health declines in old age and disease become more common. Some scientists have pointed out that there are two different reasons why older people have more health problems. They say that the first reason is that ageing itself causes health to decline. The second reason is that diseases require a long time to develop and they will therefore only manifest in older ages. So this reason doesn’t see ageing as a cause of diseases. Luckily for us, nowadays we can cure many health problems. Acute health problems, like aftermaths of infections or accidents, can often be treated to recovery. But some problems, like diabetes, can’t be treated to recovery. The symptoms of chronic health problems can be managed and this helps the individual to lead a normal life. Because of senescence, older people are prone to suffer from chronic diseases. Sometimes even from more than one disease at a time. Because of this, old people may have a hard time carrying out everyday activities. What’s actually the most important, is how older people think about their health. The presence of a disease doesn’t mean that one sees himself or herself in poor health. Even when they were diagnosed with several diseases, older people described their health status as good. It seems that people need to pay attention to older people’s perceptions when they discuss health in old age.

A positive approach

The World Health Organization (WHO) sees health as more than a physical state and the organisation therefore suggested a broader term. In 1948, they proposed that health is not only a physical state, but also a social well-being state. They were the first to include the subjective aspect of social well-being in the terminology of health. But the question that arose because of this, is what social well-being actually is. Gerontologists say that social well-being is a good quality of life. They see health in old age as a question of quality of life. According to them, quality of life has two dimensions. The first dimension is health related, like pain and discomfort. The second dimension is not health-related. This second dimension refers to personal resources. Some of these might be the capability to find spiritual satisfaction or the capability to form friendships. Because of this dual nature, good health in old age can be maintained by preventing diseases and enhancing personal resources. Strategies for promoting healthy ageing need to look at both ways to be healthy.

Because of the increasing healthy life-expectancy, old age has been given a positive image. There are now new concepts of old age, like the concept of successful ageing and active ageing. Active ageing is optimizing opportunities for health, participation of security and with this, enhancing quality of life. Successful ageing looks a bit like active ageing, but it has been received a more critical reception. According to Rowe and Kahn, successful ageing is a combination of three elements: absence of diseases and of risk for disease, engagement in productive activities and maintenance of cognitive and physical abilities. Both active ageing and successful ageing underline the activities of older people. Successful ageing does not draw attention to quality of life, while active ageing does. The term ‘ successful ageing’ can be seen as troublesome, because if successful ageing exists, than unsuccessful ageing must also exist. What is that? According to Baltes, the concept of succesfull ageing might be an oxymoron, because the concept implies that people age successfully if they do not age at all. Because of this problem, discussions on healthy ageing do not really focus on successful ageing, but on active ageing and quality of life.

Facilitating healthy ageing

In the previous section, a couple of possibilities for the achievement of healthy ageing were discussed. The three most important approached for reaching healthy ageing are learning from health promotion strategies, slowing down the ageing process and utilizing the potentials of preventive medicine. Health promotions focus on reducing the risks leading to four diseases in particular: lung diseases, diabetes, cancer and cardiovascular diseases (also strokes). The promotions suggest that moderate intake of alcohol, not smoking, a healthy diet and enough physical activity reduce the risk of getting these diseases. Also, a stable social and psychological situation seems important because this situation helps people to cope with the challenges of old age (losing a spouse). Another strategy is slowing down the ageing process. Ageing can be seen as a life-long process. The foundations of healthy ageing are laid during ones childhood and youth. If you have a healthy life-style at a young age, the chances of you ageing healthy will be higher. Adopting a healthy lifestyle at a young age is a strategy to slow down the ageing process. Anti-ageing medicines are also seen as a potential means for slowing down ageing. These medicines can vary greatly, because they can be vitamin pills, hormones or herbal components. However, there is not really conclusive evidence that taking anti-ageing medicine slows down the ageing process. It’s therefore better to focus on maintain a healthy life-style. Another approach in promoting healthy ageing is to utilize the potentials of preventive medicine. Preventive medicine is for people who did not yet fall ill. This strategy tries to avoid that the healthy individuals develop diseases. Preventive medicine makes use of the other two approaches just described. It also finds an early diagnosis of diseases important, because this allows for higher chances of recovery and more effective treatments. Early diagnosis can help us to ensure good health in old age.

The current state of Europe

With health-related information, an insight in the current state of Europe can be found. We have information about the living situations of older Europeans and how governments react to population ageing. There is a big difference in the health status of older people across Europe. Europeans who reached the age of 65 years in 2009 could expect to live for 15-21 more years, depending on the country in which they were born. The countries with the highest remaining life expectancies at age 65 lie in Northern, Southern and Continental Europe. In Eastern Europe, the countries with the lowest life-expectancies at birth lie. You can see the life-expectancy of different countries in Figure 2.1 on page 20 of the book ‘Old age in Europe.’ Slovakia has the lowest remaining healthy life expectancy, which is 3 years and the highest one is 14 years in Sweden. Continental and Northern Europe have the highest healthy life expectancies and the lower healthy life expectancies are concentrated in Southern and Eastern Europe.

The capabilities of older people also vary across the countries in Europe. Some older people confirmed that they were severely limited in their everyday activities. The number of people with limitations in their activities increases with increasing age. This is common in all countries. What does vary with countries, is how many people are limited and how quickly the limitations progress with age. In the Netherlands and Switzerland few older people are limited in their everyday activities. In Greece and Germany, many older people are limited in their everyday activities and with increasing age come increasing numbers of people with limitations. But there is no clear geographical pattern when it comes to capabilities.

The differences between countries in life expectancies and capabilities of older people are caused by diseases and health problems. The state of frailty is the state in which older people are especially vulnerable to have accidents or fall ill. Frailty can be considered a disease if three or more of the following criteria are present:

  • Self-reported exhaustion

  • Unintentional weight loss (4.5 kilograms in one year)

  • Low physical ability

  • Slow walking speed

In 2004, 3% of male and 7% of female Western Europeans aged 50 years and over were frail. There are two life-style factors that are often held responsible for diseases, premature death and frailty: lack of physical activity and smoking. A lack of physical activity is especially common among European women with a low educational level and smoking is especially common among European men with low income. Also, researchers have found that the further north older Europeans live, the more physically active they are.

Certain diseases play an important role in older age. These diseases are related to the heath and blood vessels (cardiovascular diseases), diabetes and cancer. Cardiovascular diseases are the leading cause of death in developed countries. They were responsible for almost every second death in Europe in 2008! The most common cardiovascular diseases among Europeans aged 65 years and older are ischaemic heart diseases (heart attack) and cerebrovascular diseases (stroke). The second most important cause of death in Europe is cancer. The most common forms of cancer that affect Europeans aged 65 years and older are cancer of the breasts, lungs, colon and prostate glands. Diabetes is also a common disease in Europe. Diabetes is a chronic disease and the prevalence will also increase as populations age. Older people do not only suffer from physical health problems, but also from mental health problems. Among older Europeans, late life-depression is common. There are more depressed older Europeans in Southern Europe than in Northern Europe. Possible causes for this late-life depression is financial problems, social isolation, the death of loved ones and health problems. Another common mental health problem in late life is the decline in cognitive function, because of dementia. People with dementia lose a couple of their cognitive capabilities, like their language, memory and problem solving ability. Researchers think that more and more people in Europe will suffer from dementia, as the population ages.

Taking care of frail Europeans

The health profile of Europe changes as the European population ages. Because of this, care arrangements also need to change. There are two care arrangements older people benefit from: formal arrangements and informal arrangements. Informal arrangements are arrangements in which people provide unpaid care to relatives or friends. Usually, women provide this care to their parents, children or partners. The number of older family members will increase, as population ages. This can result in women having to provide care to more parents and in-laws. This increasing need for care can be hard to put together with paid work and taking care of children. However, population ageing also goes together with a decrease of children in families. This will result in a lower need of childcare and this may ease the situation of informal care-providers. People stay healthy until a later age and this means that older family members might also provide informal care. This might ease the situation of middle-aged women in informal care arrangements.

Table 2.1 on page 23 of the book ‘Old age in Europe’ shows how many Europeans receive informal help or care and how many older Europeans provide informal help or care. 15% of older Europeans in Spain received informal care, while in Germany this percentage was 28%. 15% of older people in Spain provided informal care, while in Denmark this percentage was 48. More help is provided and given in Northern Europe than in Southern Europe. Also, the table shows that in many countries, older people help out more than they receive help. This fact shows that old age is today a time of good health and activity for many people. European policies are aware that informal caregiving is important and quit common and they try to support the informal caregivers. They introduced financial support in a couple of countries in Europe. But older Europeans can also receive formal care arrangements. These are arrangements in which paid professionals provide care in the homes of frail person or in institutions, like nursing homes. These professionals can belong to the social care sector, the health care sector and in a couple of countries like the Netherlands and Germany, to a separate long-term care sector. That sector is specialized in the provision of care over a longer period of time. The older users have to cope with several health problems and their care needs change over time. Because of this, they might need services from different health and social care providers. Countries spend different amounts on formal care arrangements. Countries with high public health care expenses are located in Continental and Northern Europe. The countries with the lower public health care expenses are located in Eastern Europe. There are also more long-term care facilities in Northern Europe than in Southern Europe. Northern Europe has also more long-term care workers than Southern Europe and Eastern Europe.

Policy-makers know that Europeans live longer and that their life-expectancy will continue to increase. They are happy with this development, but is it desirable to live longer? One can’t only look at the number of life years gained in order to decide whether longer lives are desirable. You must also look at the quality of the additional life years. You must see whether the additional years are healthy and free of disease. There is a discussion between researchers about the relation between health problems (called morbidity) and longer lives. There are two hypotheses about this: the first one describes a compression and the other one an expansion of morbidity. The first hypothesis states that the most severe health problems are concentrated in the last years of life. This means that living longer goes together with more years in good health and health problems will arise in a higher chronological age. The expansion of morbidity hypothesis states that the number of life years increases when the life-span increases. This means that living longer will result in spending more years battling health problems. Evidence has shown that both hypotheses might be in part accurate. It seems that the most severe health problems are concentrated in the last years of life and the years before that are characterized by chronic diseases which do not lead to disability. A person who can cope with chronic diseases can have a pleasant old age. Health care professionals should look at attitudes and social factors when they try to prolong lives. Longer lives can be something to look forward to when there is a good medical care, a right attitude and a well-developed social network.

Access: 
Public
Gerontopsychology: Ageing is All in Your Head - Martin, Theill, & Schumacher - 2013 - Article

Gerontopsychology: Ageing is All in Your Head - Martin, Theill, & Schumacher - 2013 - Article

Gerontopsychologists look at the effects of ageing on the brain and the personality. They also look at how cognitive functions change when people age and how individuals can cope with the changes to maintain a high quality of life. One of the most important age-related cognitive changes is dementia. That is a disease that causes memory loss and capability loss. Gerontopsychology looks at the stability and changes of behaviour and experience of people in their later life. Gerontopsychology thinks that processes of development and change when one ages is not a unidirectional decline process, but a process that can be stable or multidirectional. Gerontopsychology looks at the developmental potentials of older people and at their environmental and personal resources. The research has shifted from pathological to healthy ageing.

Theories and concepts

In this section, the basic concepts of Gerontopsychology shall be discussed. The emphasis of this will be primarily on cognitive ageing. Important concepts in this are the concepts of quality of life and cognitive health. The terms look at functional concepts of competence. Cognitive health is not just the absence of disease, but also the preservation of a multidimensional cognitive structure. This structure allows older people to maintain a sense of purpose, the abilities to function independently, social connectedness and to cope with illnesses and functional deficits. Quality of life looks at a person’s resources. Somebody who thinks that his/her resources are functional to perform activities that serve goals, will have a higher quality of life. So both concepts look at the environmental and individual contexts and they also imply that characteristics of a person’s resources are not the only thing important when measuring performance, but that one also needs to look at the integration into social structures and the adaptation to different situations.

Cognition consists of multiple abilities and these abilities have different developmental courses. The level of most cognitive abilities declines differentially across adulthood. Usually, cognitive abilities are categorized into two types of intelligence. These types are fluid intelligence and crystallized intelligence. Fluid intelligence is the process speed, working memory, recall, verbal fluency and reasoning. Research has shown that there is a decline in measures of fluid intelligence when someone ages. Crystallized intelligence is the experiences and culture-dependent performances that somebody learns. In general, cognitive abilities decrease with increasing age, but some people maintain their cognitive abilities in old age and some even increase the cognitive abilities. There are individual differences in cognitive ageing and there are also differences between generations.

There are four main theories which researchers use to explain the differential age-related changes in crystallized and fluid intelligence. Salthouse’s processing speed theory suggests that age-related difference in performance are due to a general decrease in speed of performing mental operations. According to the theory, a slower processing speed is related to all aspects of cognition, even if they don’t have a speed component. Craik and Byrd argue that the age-related decline in cognitive functioning is due to reduced processing resources. Processing resources are abilities to manipulate and process information (measured by working memory tasks). Other researchers see the decline in inhibitory control as the cause for cognitive deficits. Inhibitory control is the ability to suppress currently irrelevant information or behaviour. This theory suggests that older people have more problems to inhibit prior information from working memory and that because of this, the work space for new material is reduced. Yet other researchers relate sensory functions (visual and auditory) to age-associated changes in cognitive function. Some researchers have found that auditory and visual functions together can account for a large amount of the variation in intellectual functioning. This is also called a common cause hypothesis and it states that declining sensory function will have a negative effect on all cognitive abilities. All these theories can account for age differences in cognitive abilities. All the theories just mentioned differ in the focus on basic mechanisms. Schaie thinks that most of the age differences in cognitive abilities tests result from cohort differences rather than age differences. This means that factors other than age and practice in specific skills should be used to look at the development of cognitive abilities. Some of these factors are generational differences in schooling and the use of technology.

Cognitive health and quality of life

The concept ‘cognitive health’ is getting more and more popular among scholars. As mentioned shortly in a previous section, cognitive health refers to a person’s ability to adapt their cognitive performance to changes in the environment and the ability to make the cognitive functioning stable. Most research on cognitive ageing focuses on interventions to improve impaired cognitive functioning or on the prediction of cognitive decline, but cognitive health research looks at which factors may support stable levels of cognitive functioning. Often, cognitive health goes together with the term ‘plasticity.’ When someone adapts successfully to the environment, we speak of health cognitive development. Successful adaptation of a person also leads to neuronal and behavioural plasticity. Cognitive plasticity is often defined as a person’s cognitive capacity under certain specific conditions. Cognitive plasticity is seen in neuronal and behavioural data, because there is a relationship between cognition for certain cognitive abilities and neuronal activation. However, researchers still don’t know the exact relationship between these two. There are researchers who have found that there are small or negative effects in older people between the reduction in cortical volume and cognitive performance. According to some, cognitive plasticity can exist even if the neuronal plasticity has been compromised, this is called cognitive reserve. Passive cognitive reserve sees reserve as the result of brain size and synapses and the active cognitive reserve theory argues that the brain actively copes with pathology. This means that the brain is able to use brain networks more efficiently or to acquire new brain networks. This has been seen in human beings with higher levels of intelligence and who had more education and a high level of occupation. Research has shown that people with lower intelligence show functional deficits after brain damage and people with high intelligence in the same situation maintain their performance level. Being active during the youth can build up cognitive reserve and this will result in long-term plasticity in old age.

Researchers look much at the quality of life when they study the outcomes of health-improving interventions in old age. There are many instruments that measure quality of life, but there is still no firm consensus on what quality of life exactly is. The World Health Organization sees quality of life as a meta-disciplinary construct which involves psychological, medical and sociological aspects, but that broad definition doesn’t clearly separate quality of life from similar constructs, like life satisfaction. There are two main approaches to determine quality of life in old age. The first one is the so-called sQOL which measures the subjective evaluation of a person’s life situation and quality of life and the second one is the oQOL, which looks at the quality of life of a person from the outside, like measuring health impairments. The first approach thinks that quality of life is a subjective state and that is must be measured through subjective statements. The subjective quality of life looks at the discrepancy between a person’s current life situation and his/her ideal life situation.

There are different instruments that measure sQOL and the particular instrument determines which type of quality of life (social relationships, physical health, environment) is studied. It is therefore difficult to make direct comparisons between different instruments. The second approach looks at objective measures of quality of life and sees quality of life as better the higher the given resources of an individual are. The oQOL can be determined more reliably, without a person’s report bias and without a statement from the person whose oQOL is being measured. This is a positive think, because people with dementia might not make a reliable statement. But, this approach doesn’t take into account inter-individual differences in the availability of resources to achieve goals. There is also a new model, called the fQOL model, which defines quality of life as an integration of multiple subjective representations of the functionality of a person’s resources. This model assumes that quality of life is higher, the more strongly a person represents his/her resources as being functional to perform complex activities that serve central goals. This model is different than the other two. It does use subjective assessments, but these are not satisfaction judgments, but functionality judgments.

Coping strategies

The resources of a person and the person’s ability to adopt to different situations and environments has an impact on cognitive health and the quality of life. There is a mechanism to achieve a successful and healthy personal development and also a healthy adaptation and that is the selective optimization with compensation (SOC) strategy. Choosing tasks that are of high individual importance and that match a person’s abilities is the selection part of the strategy. This selection is divided into elective selection (ES) and loss-based selection (LS). Elective selection is guided by social norms or preferences and loss-based selection is a shift in personal goals due to a loss of external or internal resources. Selection thus leads to a smaller number of alternative options and the persons can concentrate on a reduced range of achievable goals. Old people usually lose resources and their number of achievable goals will also decrease. In order to achieve a selected goal, a person has to optimize his/her strategy by refining and deploying resources (that is the O in SOC). Training, a good motivation and learning new skills can help with optimization. Compensation refers to acquisition and utilization of alternative means to reach certain goals and keeping performances at a desired level, despite the actual or anticipated decreases in resources.

A concept that looks a bit like the SOC is the concept of resource orchestration. This concept assumes that performance in complex cognitive tasks requires using multiple cognitive abilities in different degrees during the performance of the task. This means that multiple skills have to be timed and orchestrated. This means that an improvement in elementary abilities will probably not lead to large improvements in the complex behaviour. interventions of this approach look at individually meaningful goals and they focus on the orchestration process itself. This means that they help to identify the goals, the relevant abilities and to optimize decisions when to use certain strategies.

The current state in Europe

Europe has the highest median age of the population in the world. This brings a couple of challenges to societies. One of these challenges is the increase of the prevalence of dementia. Dementia causes a person to lose his/her cognitive abilities faster than they would lose it during the normal ageing process. This will result in memory loss and even the loss of physical functioning. Older people suffer more from dementia than younger people (5.9% to 9.4% of people aged 65 and up in Europe and 0.1% of younger people). 6.2% of people aged 60 and over in Europe suffer from dementia and 60-70% from these people have Alzheimer’s disease. This rate is almost the same as the rate in other developed regions, like Australia and North America, but it is higher than those of other regions, like Africa and Asia. This is actually not so strange, because the more developed regions have longer life expectancies. The number one risk factor of dementia is old age. In Europe, more people life up to an old age and there will therefore also be more people (proportionally) with dementia than in Africa and Asia. Researchers estimate that in the year 2050 the number of dementia diseases in Europe is going to double and that the number in less developed regions is going to more than triple. This is because the population of the less developed regions is going to increase in the next 40 years. In Europe only the part of the population aged 60 years and older is going to increase and other parts of the population are expected to decrease. Dementia costs Europe a lot of money and it is important to determine the factors that can help a successful cognitive ageing process and that stop the development of dementia. It is also important to arrange good care for people who already suffer from dementia. It is therefore important to look at the individual and environmental resources that can contribute to maintaining the functional level and the ability to adapt to the environment.

Stopping dementia

Not everybody will lose his or her cognitive abilities or develop dementia. Most of old people are able to maintain their functional level to a very old age. To figure out why some people suffer from dementia and others do not, one first needs to know which environmental and individual resources may support successful cognitive ageing without developing dementia. Although people have a decline in cognitive and physical resources, certain resources (knowledge and strategic skills) may increase with age. Most resources can be improved through training interventions. Researchers therefore should identify these resources and look at how they interact and look at the factors that may influence them.

Research has shown that cognitive and intellectual stimulation contributes to a cognitive healthy ageing process and that it seems to prevent dementia. It has also been shown that education has a protective effect on dementia. However, what’s not clear is if education is able to prevent dementia or if educated people are just diagnosed at a later date because their capabilities compensate for the losses for some time. There are also physical conditions that have a protective effect on dementia. For example, the absence of diabetes has been reported to have a protective effect on dementia. However, many reported effects are based on retrospective data and causal effects actually require intervention studies. A couple of studies have looked at the effects of cognitive training and they have found positive effects for cognitive health in older adults and also in people who are in risk groups (people with mild cognitive impairment) or who are already suffering from dementia. Other studies have shown positive effects of physical training interventions on cognitive abilities. The studies have also shown that physical training improves cognitive function. Physical training may thus protect against cognitive decline and dementia. Global cognitive stimulation is more effective than concentrating on a specific functioning. It is therefore better to have an enriched environment that allows a person to engage in activities that stimulate physical, cognitive and social skills than just concentrating on one of these things. Sadly, there are only a few studies that have looked at the effect of combining physical and cognitive trainings. More research has to be done on this subject. The research should look at stimulating these things simultaneously, because in daily life, different motor and cognitive resources engage together.

Strengthening the resources is not the only thing that should be done to help older people with cognitive impairments. People with dementia also have specific care needs and require specific housing because of their disease. The environment should be adapted so that there is an optimal person-environment fit that can provide adequate care and that allows a person to life an independent life for as long as possible. However, one needs to consider the individual resources and goals of the person in order for an optimal person-environment fit. On must look at the social context situation of a person, at the general mobility and at the presence of other mental and physical diseases. The different countries in Europe have different care provisions. In certain countries, especially in Southern Europe (Italy, Spain), the family predominantly provides care. The family takes care of the relative who suffers from dementia and patients in those countries are thus less frequently institutionalized. However, this also means that these patients are not able to benefit from professional care and the family can also be burdened with the patient. This may also be a burden for the patient. In Western Europe, many people with dementia are institutionalised, but the majority of patients with dementia are cared for at home. Many countries there provide help at home or make an institution as home-like as possible. One example of this is a small-scale living or group living arrangement, which can be found in the Netherlands, Germany and the United Kingdom. These arrangements have six to eight people living in a place which has a 24/7 care and surveillance by a couple of staff members. Certain rooms are shared, like the living room and kitchen, but some rooms are private areas that have the private stuff of the patient. These arrangements provide intensive professional care and a homelike living situation. The care and treatment can be adapted to the individual needs of the patients. Care providers should provide the adaptation of the environment to the available resources of the patients and the individual needs of the person. This will result in different forms of care. Providers also need to support independence and they should let the patient feel as much in control as possible.

Access: 
Public
Social Gerontology: Older People and Everybody Else - Victor - 2013 - Article

Social Gerontology: Older People and Everybody Else - Victor - 2013 - Article

Social gerontology looks at the social contacts of older people with others. It looks at interactions of older people with relatives and friends and it also looks at which roles older people play in society. When people get older, social roles and social interactions change. The roles and interactions also vary across Europe. There are different disciplines involved in social gerontology. The social sciences, arts and humanities are involved in social gerontology when it comes to the study of the social context of ageing, the review of policies and interventions and the impact of population ageing upon society. There are three areas of activity that social gerontology focuses upon:

  • The micro-level: This approach looks at the individual level experience of old age and tries to answer questions related to the meaning, experience, interpretation and social roles. Investigation for this approach tries to help older people better understand the meaning of certain things, like loneliness. It also looks at the value and meaning older people give to different relationships and different modes of engagement, like computer and phone contacts.

  • The meso-level: This analysis looks at the importance of social context and social structures for the experience of ageing for individuals and groups. This perspective looks at the influence of ethnicity, gender and class on the experience of later life. This research looks at the inequalities in the experience of ageing

  • The macro-level: This perspective looks at the social context of ageing at the societal level. This perspective looks at the demographic, cultural and economic changes that result from the increase in the numbers of older people. The main focus has been on the societal effects of population ageing but it is now looking at global trends, like globalisation and the interactions with population ageing.

Theories and concepts

Before looking at certain theories, one must first know what is meant by theory in the context of social gerontological research. One must first know what a theory is and how useful it is in gerontology. The word ‘theory’ has different meanings in different contexts and fields of study. Basically, theories help people to explain a series of empirical findings or observations. But, theory in the field of social gerontology has been perceived as problematic. It appears that there is an imbalance between the accumulation of data and the development of theory. Researchers also claim that they have collected a pile of data that has little attention to basic assumptions and big theoretical issues. However, not everything is negative in this field. There are also a broad range of theoretical perspectives in gerontology. Theories can be classified in different ways and many typologies may be applied.

Activity, disengagement and continuity theory

A theory of age that operates at the individual level and that arose in the early years of gerontology, looked at activity, disengagement and gerontology. This theory arose from sociology. Society was seen as mirroring a biological entity and all component parts, like family, work and education were interrelated to produce an ordered society. Together with the concern that population ageing is a social problem, this paradigm produced a couple of theories that were linked to each other. These theories were disengagement, continuity and activity theories. These theories focus on explaining social relationships in later life, but they also kind of show how people should age. Disengagement theory was first seen as a disengagement from the workplace and other social relationships. People saw it as inevitable and a natural process and people thought that society benefited from it, because it facilitated an easy transfer of roles across generations and individuals. This theory suggests that there is a triple loss for the individual. There is a loss of roles, a reduction of engagement with social values and a reduction of social relationships. These theories have implications at the level of the individual and the experiences of ageing. When you look at social relationships, disengagement favours older people withdrawing from social engagement and implies that isolation is like disengagement theory in action. However, scientists have empirical data describing reduced social engagement with increasing age, but the adaptive nature of these changes is unproven and thus there is no support for the disengagement theory. This theory also has a bit of critique upon it. The disengagement theory devaluates ageing implicitly, and the importance of older people in society and their contribution to society is devaluated.

Activity theory accepts the maintenance of roles and social relationships as the key to successful ageing and posits that new activities and roles should be adopted, in order to compensate for the roles lost through retirement, or other transactions, like widowhood. From the activity theory perspective, the maintenance of social relationships in later life is seen as central to a successful old age. This perspective is maybe the first contemporary theory to promote the idea of successful ageing. Continuity theory is less prescriptive and emphasises that older people will seek to preserve the activities and social relationships acquired over a lifetime. It also proposes that any changes will be adaptive. Continuity theory is more adaptive and offers the loss of some forms of activity and the possibility for new activities.

Critical gerontology

There was some critique on these functionalist theories and the critique was that they fail to engage with the influence of important social structures, like class, gender, age and ethnicity in shaping the experience of ageing. Also, they do not focus upon the experiences of individuals. Functionalists did not examine how certain factors, like material resources, may promote or limit the opportunities for social interaction. There is little evidence that material resources are associated with both isolation and loneliness. This doesn’t seem strange, because a lack of resources may inhibit social engagement. Contemporary theories have tried to address these limitations. Critical gerontology is an influential school that was developed from the notion that old age is socially constructed by interactions with the social context and constrained by socio-structural factors like class, race and gender. One of the theories within the critical gerontology was the political economy of old age. This theory tries to understand the position of older people and the experience of old age as it relates to an advanced capitalist society. A critique of critical gerontology was the it over-emphasis upon social class and that it doesn’t focus enough attention on autonomy ascribed to older people.

Lifecourse perspective

Lifecourse has been important in the development of gerontological theorising and frameworks. This perspective has several interpretations. Grenier differentiates between the personological approach and the institutional approach. This last approach focused more upon later life and it looks at the lifecourse as a foundation for social organisation. Lifecourse consists of a series of stages which people pass through as they get older. Often, but not always, some significant event marks the transition from one stage or role to the next. Lifecourse is differentiated into smaller segments by certain subgroups, like pre-school, middle age and adolescence. These are seen as distinct phases. Lifecourse is also no a single entity, but consists of different spheres, like education and family. Three different types of time must be distinguished, in order to understand the lifecourse. These three are historical time, biological time and social time. The historical time defines the temporal context and the social time relates to the meaning that is attributed to the different stages of life. These dimensions inter-relate and they produce a pattern of lifestages. This perspective can highlight how certain patterns of disadvantages and advantages can influence the experience of ageing. This means that social engagement in later life can be understood within the framework of the lifecourse of a person in terms of the opportunities a historical and cultural context has offered them, the social advantages or disadvantages somebody acquired over a lifetime and the personal preferences of that person.

The current state of Europe

Ageing occurs in a social context which ranges from the micro-scale (individual), to the meso-level (community) and to the macro-level (society). The writers argue that to understand social engagement, one must look within the life course perspective and at the influence of historical and cultural time and structural factors, like gender and class. Ageing and later life is not a homogeneous experience and it doesn’t affect every person within the same society in the same fashion. All older people are not alike and the characteristics that existed before the person got old, have a strong influence across the life course. When we are old our health, material and social resources are influenced by our experiences prior to the old age. With the popularity of constructs like ‘successful ageing’, the importance of the social context for the shaping of the experience of old age has assumed greater prominence. Many scholars argue that successful ageing consists of longevity and quality of life and that these two are prompted by the interaction of three types of factors. The first is social engagement, the second is reduction of disease and the third is promotion of high levels of mental and physical functioning.

Social engagement

Studies have looked whether social relationships in later life are experienced in the same way by people of similar ages across Europe. One big survey that was held, was the European Social Survey and it gives us more information about the frequency of contact with friends, relatives and colleagues across a range of European countries. The survey also gives more information about loneliness experienced. Northern European countries like the Netherlands and Norway show low levels of loneliness (less than 10%), high levels of weekly contact with relatives and friends (+60%) and 20% of these people rate their levels of social engagement as higher than their peers. The former communist countries show the opposite pattern and the countries in South Europe occupy an intermediate pattern. The Survey of Health, Ageing and Retirement in Europe gives information into the involvement of older people in Europe. This involvement was involvement in a formal social organisation. The survey found that approximately 31% of the people aged 50+ participated in a formal social organisation. Of course, there are variations in levels of community based participation between different countries. Again, social participation was highest in northern countries like the Netherlands and Sweden, but also in Switzerland. The rates were lower in Italy, Spain and Eastern European countries.

Most surveys look at social relationships on an individual basis, but older people have a range of relationships that include family, friends, neighbours and colleagues. These relationships are seen as the social network of an individual and they provide emotional, social and practical support across the lifecourse. The convoy model of support suggests that the convoys of support that go along with us across the lifecourse vary between individuals and over time. This suggests that the oldest old reduce their number of ties and they focus on the most meaningful relationship and disengage from the peripheral ones. Research has shown that social networks are larger in Northern European countries than in Southern or Eastern European countries. Researchers have also looked into how satisfied old people are with their relationships. In one study, satisfaction was asked in two ways and the results of these two ways were compared. The first way was to self-rate the social relations on a 5 point scale and there was no distinction between family, neighbours or friends. The second way was done by giving the older people two vignettes with stories about a person on them. They had to rate how satisfied the individual in the vignette was with their relations. According to the data, people were most satisfied with their relations in the Netherlands, Denmark, Belgium, Germany and Sweden and least satisfied in Italy, Greece, Spain and France (the only East-European countries that were surveyed were Poland and the Czech Republic). However, the researchers of that survey saw that the results were different when only looking at the vignettes. When they only looked at the vignettes, the countries highest in satisfaction were Sweden, Italy, Germany and Denmark, those average in satisfaction were France, Poland, Belgium and the Czech Republic and those lowest in satisfaction were Spain, Greece and the Netherlands!

Social gerontology focuses much at the experience of loneliness and isolation in old age. Loneliness can be conceptualised in many ways, but all definitions mention the deficit between the desired quantity/quality of social relationships and the reality of a person’s social engagement. This gap is seen as the feeling of loneliness. Research shows that loneliness is one of the most feared aspects of growing older. There are different authors that have studied the distribution of loneliness across Europe. The measures used to measure loneliness vary across the studied, but there is a similarity across the studies in terms of the distribution of loneliness across Europe. The similarities are that there is a group of former Soviet bloc countries with rates of loneliness of +20% (Russia, Hungary, Ukraine), there is a group of northern European countries with low rates of loneliness of 10% and under (the Netherlands, Denmark, Norway, Germany) and there is an intermediate loneliness group were loneliness is in the 15-20% range (Spain, France, Austria).

Loneliness in the United Kingdom

Loneliness is quite a complex thing and it is culturally, temporally and historically situated and it is variable in the experience of old age. There have been many studies done that focus on the prevalence and risk factors for loneliness in the United Kingdom. The studies that were done in the late 1940s and early 1950s, revealed that 10% of those aged 60+ reported that they were lonely most of the time. This has remained consistent across 60 years. Researchers still do debate about the risk factors associated with loneliness. Researchers do agree that widowhood and a reduction in the number of confiding relationships show a relationship with loneliness, but they do not agree on whether age and gender are independent risk factors for loneliness. In the United Kingdom context, physical health isn’t a risk factor for loneliness, but expectations about health and quality of life are. There is also a link between loneliness and material resources. The old population in the United Kingdom is dynamic, because after the WO II, many migrants from the Caribbean and South Asia moved to the United Kingdom and they are old now. Research shows that these populations show high rates of loneliness. This suggests that the factors that influence the context for social relations and the experience of social relations will be dynamic as well.

Studies that have examined loneliness longitudinally, have reported that loneliness is a dynamic experience. Some people are lonely in one period of old age, while less lonely in another. The factors associated with deteriorating loneliness are widowhood, deteriorating physical health and a decreased number of confidents. One study showed that the prevalence of loneliness shows a U-shaped distribution. The rates are highest for those aged under 25 and 65 years and over. Depression is associated with loneliness for all age groups. Poor physical health is only associated with loneliness in young adult and midlife, but not later life. For the people in mid and later life, the quality of social engagement is protective against loneliness, for young adults it is the quantity of social engagement. Different factors may protect against loneliness at different stages of life. Preventive strategies or interventions need to be developed that reflect these differences.

Globalization

Globalization influences the context within which current and future cohorts experience old age. Globalisation is the trend whereby the world is become more and more interconnected as a result of multinational organisations, increased trade, migration and cultural exchange. Some researchers say that population ageing can’t just be seen as a national issue, but it has to be looked upon at an international level;. Globalisation as a social phenomenon influences older people within developed and developing countries. This is because it widens the inequalities between the working people and the older people. One facet of globalization is the transnational community. This community results from the migration of people and families across the globe for economic and political imperatives. During the 50s, 60s and 70s of the last decade, many migrants from former British colonies moved to Britain. These migrants were from the Caribbean, India, Pakistan and Bangladesh. These big migrant populations and their ageing in the European countries has created a complex web of social relationships between the country they came from and the country where they live in now. This brings challenges for social policy. Gerontologists are now investigating the experience of ageing within a transnational context. They look at the complexity of ageing experienced by migrants and how the outflow of migrants influenced the experience of old age for those left behind in the country of origin. Gerontologists have much work to do and many challenges up ahead, because of the globalisation of the world.

Access: 
Public
Mild Cognitive Impairment and Normal Aging - Rog & Fink - 2013 - Article

Mild Cognitive Impairment and Normal Aging - Rog & Fink - 2013 - Article

Scientists these days have a good opportunity to improve their knowledge about the function of the aging brain, because people live longer than ever before. In the United States, 13% of the citizens are 65 years and older. The life expectancy at birth there is 81years for women and 76 years for men. Researchers estimate that one in five citizens by the year 2030 will be seniors and they also think that the oldest old (85 years and older) will be the fastest growing segment of the population. Given these numbers, it is important for research to focus on normal and pathological ageing.

We now know and accept that that some degree of cognitive decline associated with ageing is inevitable and these declines are different for every person. There is a variation in cognitive performance in areas as fluid intelligence and memory when people age. When people age, there is an increase in the proportion of old people who show normative age-associated cognitive decline. However, there will also be an increase in the pathological cognitive decline. There are some aspects of cognition that remain relatively stable with normal ageing. Some of these are vocabulary, storage of knowledge and implicit memory. The decline that often goes together with normal cognitive ageing is a decreased efficiency in information processing in multiple areas. These areas are speed of processing, short-term memory, reaction time, verbal fluency and executive control. Visual-perception also declines with age.

Slowed processing speed is an important cognitive change in the ageing brain. Research has found that visual-motor tracking and sequencing slow with age. Older people have a slower processing speed in general and this mediates cognitive efficiency by restricting the speed at which cognitive processes can be executed. The quality of performance can also be affected by reduced processing. This is because there is a decreased quantity of information processed that is necessary for completion of the task. Also, the products of earlier processing can be lost by the time later processing happens and this makes the integration of relevant information difficult or even impossible. Reduced processing can lead to a decrease in working memory capacity, because less information can be processed in a certain amount of time.

Also, higher-order cognitive functions, like elaboration and abstraction, can be impaired. This is because the relevant information is not available anymore in the working memory or storage. Older people have a reduced inhibition of selective attention and because of this, the changes in their working memory occur. Older people show a decreased ability to suppress the processing of irrelevant stimuli. Their attention will be dis-regulated because of this and this will also have an effect on different aspects of executive performance, like suppressing responses. Cognitive ageing is also related to poorer effortful processing, but automatic processing remains relatively intact. Normal age-related changes in language function are an inefficiency in word retrieval. This means that older people have more trouble in finding words and this is also called the ‘tip of the tongue’ phenomenon.

Structural brain changes

Normal ageing goes together with a couple of changes in brain structure, like volumetric shrinkage, loss of dopaminergic receptors, more neurofibrillary tangles and plaques and a decreased white matter density. The most thinning and shrinking of the brain occurs in the hippocampus, cerebellum, caudate and prefrontal areas. Ventrical volumes increase in old age. Decreases in white matter density are most common in frontal or occipital regions of the brain. White matter changes result in cognitive slowing. This is because the function of white matter is to transport signals between different areas of the brain via myelinated axons. Myelin integrity degrades with age and the speed of cognitive processing will therefore also degrade. The loss of dopaminergic receptors contributes to attentional dis-regulation, difficulty with contextual processing and executive dysfunction. Researchers have proposed that contextual representations are housed in the dorsolateral prefrontal cortex and they are regulated by dopamine projections to this spot. Context processing plays a big role in attention, working memory and inhibition. Studies have found that old people have more neurofibrillary tangles than younger people. The most affected regions are the amygdala, entorhinal cortex, subiculum and inferior temporal regions. The orbitofrontal, midfrontal and parietal regions are less affected and occipital regions are minimally affected. Senile plaques (SP) are also found in older people these affect all brain regions equally, but the occipital cortex is the most spared region. People who were not demented at death, showed less plaques and tangles than people with mild cognitive impairment and dementia. Functional imaging techniques show that older people show more bilateral activation in older adults. This means that the older brain activates the contralateral hemisphere more to achieve greater cognitive benefits.

Theories of ageing

Researchers proposed that abilities that are relatively independent in early life (cognition, sensory ability), are more interrelated with old age. This can be seen as a decrease in neural specificity. Regions that respond selectively in younger adults change and respond to a wider array of inputs in older adults. In older adults, prefrontal activation is associated with decreased parahippocampal activation and hippocampal volume shrinkage. In younger people, activation in the parahippocampal regions is associated with learning new material, but in older adults there is more prefrontal activation and this suggests that greater frontal activity may be a compensatory mechanism for decreased activation of other regions.

Salthouse’s processing-speed theory of cognitive ageing proposes that a wide range of cognitive task performances are limited by the imposed constraints on the speed of processing. Slow processing speed can have an effect on cognition in two ways. The first is that cognitive operations are executed too slowly to be fulfilled successfully in the available time and the second is that the amount of available information that is necessary for higher-level processing is reduced. This is because early processing is not available anymore when new processing occurs. Complex operations depend on the products of simple operations and that’s why they are most affected by slow processing speed. The accuracy of performance is dependent on the number of operations that can be carried out in a given time period. Due to disruptions in the synchronization of signals, the amount of simultaneously available information may also be reduced.

According to the scaffolding theory of ageing, structural brain changes are accompanied by efforts of the neural networks to maintain homeostatic cognitive functioning in the face of these changes. So, the brain function will change through the strengthening of existing connections, non-use of faulty connections and the formation of new connections. Scaffolding is often seen as the brain’s normal response to challenge. The neural networks shift from broad and dispersed to a specific circuit of neural regions. The regions will have dominant control over functions and the initial broad networks will be minimally active and they remain available for compensatory processing. Scientists think that scaffolding maintains healthy cognitive functions, when neural degradation occurs. The circuits of scaffolding can give us complementary, new or supplementary ways to complete cognitive tasks and these circuits reside largely in the prefrontal cortex. However, scaffolding networks are less efficient and more prone to error than honed circuits, because honed circuits are highly functionally interconnected. According to the theory, this will result in the observable cognitive decline seen in older adults.

Individual factors

There is variation in cognitive performance in older people, especially in the older old. Because of this, it is important to examine the individual difference factors related to the cognitive ageing process. Research has found that factors that contribute to cognitive reserve or cognitive decline are education, physical health, occupational complexity and diet. Cognitive reserve is ‘caused’ by a couple of processes: richer connections and organization between neural circuits, changes in intracellular signalling pathways and alterations in synaptic efficiency. Physical health is an important factor when it comes to the prediction of cognitive function. Medical disorders are better predictors of neuropsychological performance than chronological age. These disorders are obesity, white matter lesions, hypertension and high cholesterol. Some other measures of biological age have also been associated with poorer cognitive functioning. Higher education has been associated with preserved cognitive performance over time, but not all studies support this claim. Occupational complexity is also associated with better cognitive functioning. This is especially the case when one works with people. Once somebody retires, the cognitive benefits received from high occupational complexity cease. Once these skills are not being practised, they have no longer an effectiveness in bolstering cognitive ability.

Mild cognitive impairment

Usually a patient or his/her family refers him/her to a doctor when they perceive a decline in cognitive ability. A neuropsychologist determines whether the patient’s/family’s complaints of cognitive decline are due to normal cognitive ageing or due to an objective impairment in cognitive functioning. Mild cognitive impairment represents a decline in cognitive performance greater than would be expected for the person’s age but not sufficient enough to meet criteria for a diagnosis of dementia. Some scientists describe mild cognitive impairment as interposed between normal cognitive ageing changes and the early changes of dementing processes. It is seen as a pathological condition. The incidence and prevalence of mild cognitive impairment vary across studies, because different samples, diagnostic criteria and assessment procedures are used. The prevalence of mild cognitive impairment within the general population ranges from 1 to 19%. The original criteria for mild cognitive impairment are:

  1. Normal activities of daily living

  2. Presence of a memory complaint

  3. Normal general cognitive function

  4. Abnormal memory for age

  5. Not demented

This is useful for patients who have intact cognitive performance in every domain, except for the memory domain. Those patients with an impairment in the memory domain are labelled as having amnesic mild cognitive impairment. Other criteria were also proposed by a multidisciplinary group of experts, because mild cognitive impairment is represented heterogeneous in clinics. Some patients have only impairments in the memory area, but others have memory impairment and also another domain impairment. Some have impairments in non-memory cognitive domains. The most updates diagnostic criteria for mild cognitive impairment are:

  1. Concerns regarding change in cognition: the patient’s cognitive status has changed compared to his previous level.

  2. Impairment in one or more cognitive domains: there is evidence of lower performance in one or more cognitive domains. This performance is lower than would be expected for the patient’s age and educational background.

  3. Preservation of independence in functional abilities: these patients usually maintain their independence in daily living without help. However, some patients have mild problems with complex functional tasks.

  4. Not demented

Subtypes

Research has found several subtypes of mild cognitive impairment. One that has already been mentioned, is amnesic mild cognitive impairment (a-MCI). Some patients show an impairment in a single non-memory cognitive domain, but they perform normally in other domains. These patients will get the label of single-domain non-amnesic mild cognitive impairment (na-MCI). There are also patients with impairments in multiple domains, but who show intact activities of daily living. These patients are classified as having multiple-domain mild cognitive impairment. When a deficit in memory is present in these patients, they are given the diagnosis of multiple-domain mild cognitive impairment with amnesia (md-MCI + a). If memory impairment is not present, then the patient will receive the diagnosis of multiple-domain mild cognitive impairment without amnesia (md-MCI-a).

Prognosis

There are not only subtypes, but also multiple etiologies for mild cognitive impairment. Petersen thought there were four main etiologies: degenerative (Alzheimer’s disease), psychiatric (depression), vascular (cerebrovascular disease) and traumatic (head injury). There are also other potential etiologies that can be considered, like medication side effects, infection or toxic factors. Some subtypes are more common associated with certain etiologies than other. Patients with a-MCI are more likely to get Alzheimer’s disease than patients with na-MCI. Patients with impairments in non-memory domains, like executive functions, are more likely to get dementia with Lewy bodies. One study showed that there is a rate of progression from mild cognitive impairment to dementia of 12% per year. After six years, approximately 80% of mild cognitive impairment patients have progressed to dementia (in one study). Other studies have found rates of 10-19% per year from mild cognitive impairment to Alzheimer’s disease. 1-2% of the general population develops Alzheimer’s disease per year and this means that mild cognitive impairment places a person at increased risk for future dementia. In one study, people with a-MCI were found in one study to have a fourfold greater risk than non-cognitively impaired individuals to develop Alzheimer’s disease. However, there are also many people with mild cognitive impairment that remain stable with their diagnosis or even revert to normal. In one clinical study, 41% remained stable over time and 17% returned to normal cognitive status. This means that for some people mild cognitive impairment is an intermediate point on a continuum from normal cognition to dementia and for others, mild cognitive impairment is a transient period of cognitive decline that resolves with time.

Pathophysiology

Neuroimaging data shows that mild cognitive impairment is a unique diagnosis, different from dementia and normal cognitive functioning states. With the help of neuro-imagining techniques it was found that the retention of Pittsburgh compound B, PIB (used to image beta-amyloid plaques), in patients with mild cognitive impairment is higher than that of normal controls but lower than in in Alzheimer’s Disease patients. The patients who converted to Alzheimer’s Disease within the 2-16 month follow-up period had higher PIB retention rates than patients with mild cognitive impairment who remained stable. Other studies have also shown that patients with mild cognitive impairment who progressed to Alzheimer’s Disease, had greater volume loss than stable mild cognitive impairment groups. Studies that looked at the increase of ventricular volume have shown that the greatest volume increase is found in Alzheimer’s Disease patients, followed by patients with mild cognitive impairment and the smallest change is seen in cognitive normal.

Assessment

The referrals for mild cognitive impairment as a diagnostic consideration may come from different sources. Referrals might come from the primary care physician, psychiatrist, neurologists and self-referral. Usually, the patients or relatives of the patient prompt the consultation for memory loss. Many patients are first seen by neurologists who then give a neuropsychological referral for a more comprehensive evaluation. Cognitive impairments often involves a question of Alzheimer’s disease pathology versus other causes, like vascular cognitive impairment or Parkinsons’s plus syndrome (for example, Parkinson’s disease with Lewy body dementia). There are common differential diagnosis for mild cognitive impairment. Some of these are normal cognitive ageing, many forms of dementia, like Alzheimer’s disease, vascular dementia and Parkinson with Lewy bodies dementia and depression. Another issue that may be relevant to referring physicians, is the beginning with a cognitive enhancing medication or with a drug that treats mood disorders. The evaluation is often called for in order to track the trajectory of cognitive decline.

Clinical interview

It is important to obtain an accurate picture of the emergence of cognitive symptoms and functional difficulties when assessing people with mild cognitive impairment. It is therefore important to have an informant present at the interview so he or she can provide his or her insight into the patient’s behaviour and functionality. The informant is usually a spouse, sibling, child or other close relative or friend who knows about the patient’s history and who can tell more about the changes in functional and cognitive status. An important diagnostic criteria of mild cognitive impairment is the presence of a cognitive complaint. This complaint is subjective. Sometimes the patient complains about the his/her memory and the informant agrees, other times the informant’s report is the only evidence for subjective cognitive change. It is important to receive a thorough history of the emergence of cognitive symptoms. The evaluation of functional abilities is also important when considering the diagnosis mild cognitive impairment. Functional independence is the most important factor in the differential diagnosis of mild cognitive impairment and early dementia. People with mild cognitive impairment have intact basic activities of daily living. So, when making an assessment, the patient should be asked about his/her ability to take care for his/her basic needs (hygiene, feeding oneself) and instrumental needs (financial management, driving).

Patients and their informants should be asked about changes in behaviour or personality. These are usually early indicators of a primarily behavioural dementing process. Some of the behaviours to consider are apathy, disinhibition and behaviours that are not ordinary for that person. Also, irritability often goes together with symptoms of cognitive decline. Also, patients should be questioned about emotional symptoms and psychiatric history in order to see whether there is an increase in symptoms of depression or anxiety. Many patients with mild cognitive impairment have at least one neuropsychiatric symptom. The most commonly endorsed symptoms include depression, apathy, agitation and anxiety. Symptoms of depression that are often reported in mild cognitive impairment patients are poor concentration, pessimistic thoughts, reduced sleep, inability to feel, inner tension and reduced appetite. It is therefore important that patients are screened for clinical and subclinical symptoms of anxiety, depression, irritability and apathy. The clinician should receive a medical history and assessment of the patient’s current health status. It is also important to obtain results from neurodiagnostic studies (MRI, EEG), in case a differential diagnosis should be made. It is also important to have an assessment of the patient’s sleep quality. Also, the current and recent medications and the chronology of the patients should be reviewed, so a clinician could see whether medication has induced cognitive changes. Least, family history of dementia should be assessed.

Functional impairment

When a clinician looks at the carrying out of activities of daily living by a patient, he or she needs to know the history from the patient in order to figure out if something has changed. History from the patient should be obtained and ideally, also some information from the informant. A detailed interview is best to pick up subtle changes in functioning. According to research, patients with mild cognitive impairment report some degree of decline in their ability to handle daily tasks. They feel that they are more forgetful, have more trouble with planning and that they are less able to multitask. The ability to learn, perform higher-order executive skills and retain new information is dampened in persons with mild cognitive impairment. This usually results in less efficient daily functioning. People with mild cognitive impairment make errors in performing tasks accurately, but they are still able to complete tasks. People with mild cognitive impairment also show subtle declines in driving abilities. Some decline in functioning is observed in mild cognitive impairment patients, but it is not so severe as the decline in patients with dementia.

Cognitive impairment

Not only are self-reports and family reports about cognitive decline used to diagnose mild cognitive impairment, but objective measures of deficits in cognitive functioning are also used. There is not an exact cut-off score for what constitutes mild impaired, but mild cognitive impairment groups perform on average, 1.5 SD below normal-ageing people. The consensus criteria for scores on cognitive tests for patients with mild cognitive impairment is typically 1 to 1.5 SD below the mean for age and education. However, these are guidelines and not cut-off scores. The clinician should evaluate whether he thinks if somebody has mild cognitive impairment. For the assessment a detailed neuropsychological assessment is needed to improve the reliability of the diagnosis. The neuro-cognitive domains should be sampled and multiple measures of memory are needed. Different areas have to be assessed to determine etiology. Mood-functioning assessments should also be included.

Neurocognitive deficits

There are certain neuropsychological impairments that can be seen in patients with mild cognitive impairment who ultimately convert to Alzheimer’s Disease. One of them is a decline in episodic learning and memory early on. Patients with mild cognitive impairment show clearly defined memory impairments and only mild impairments in other domains. Patients with a-MCI show some difficulty in planning and problem solving and md-MCI patients show the most severe impairments. It is unclear why that is the case. Research has shown that patients with MCI show poorer performance than controls on tasks of semantic memory. The patients with MCI who convert to Alzheimer’s Disease show poorer immediate serial recall and divided attention than patients with MCI who do not ultimately convert to Alzheimer’s Disease. Once the diagnosis of MCI is established, the subtype of MCI needs to be selected. This is based on the results of the neurocognitive profile.

Recommendations

When a clinician reports the diagnosis of MCI to a patient and family, he or she needs to clearly explain the nature of the diagnosis. The clinician needs to convey that the patient is at increased risk for converting to dementia in the future, especially patients given an amnestic MCI diagnosis. The patients need to be told what the implications of the deficit will be, but the cognitive strengths should be highlighted in order to develop compensatory strategies for dealing with deficits and difficulties. Recommendations with a follow-up with the neurologist can also be made, to discuss the beginning of anti-dementia medication. Management with risk factors associated with cognitive decline should be recommended. Patients should also be encouraged to participate in an approved exercise regimen and maintain a healthy diet. Actively monitoring of anxiety, depression and other psychological factors is necessary. Patients should also be encouraged to maintain socially and cognitively active. Patients and relatives should also be told to monitor the functional status constantly. It is also important to schedule a follow-up appointment. However, it is difficult to determine what the best time for this is. One must looks at the severity and number of domains impaired and one must also look at the patient’s functional status. Patients with more severe cognitive impairments are further in their disease progression and patients with multiple impaired domains may reach a dementia diagnosis sooner. Therefore, these patients should receive a follow-up more sooner than patients with just one small impairment. The safest follow-up retest is a 1-year-follow-up period. However, when the family and/or patient notices a significant decline in cognitive ability or functional status, he or she should return sooner.

Access: 
Public
Assessment of Alzheimer’s Disease - Loewenstein - 2013 - Article

Assessment of Alzheimer’s Disease - Loewenstein - 2013 - Article

Alzheimer’s Disease is a horrible illness and costs many countries a lot of money annually. The greatest risk factor for Alzheimer’s Disease is age and because of the growing ageing population, this disease can reach huge proportions. Alzheimer’s Disease was discovered fifty years ago, but not until now have we known the causes of the disorder. The neuropathology of Alzheimer’s Disease are senile plaques and neurofibrillary tangles in the brain. However, this can only be seen when a person is death. Researchers think that plaque formation in these patients begins with the abnormal misfolding of a protein called beta amyloid (A-beta). This protein causes toxic amyloid fibrils twenty to thirty years before clinical symptoms of Alzheimer’s Disease are manifested. These proteins continue to get worse, especially in the frontal lobes, the posterior and anterior cingulate, striatum and precuneas. Eventually, no phosphor group can’t be added to the protein tau anymore and this will result in neurofibrillary degeneration. This is seen as neurofibrillary tangles. This, in turn, will lead to neurodegenerations of structures like the hippocampus and to synaptic disruptions. These changes can be seen on neuroimaging machines, like MRI.

There is an early neurodegeneration in medial temporal lobes and so the first clinical manifestation of Alzheimer’s Disease is seen as the disruption of short-term memories. Further on in the disease, there are more pronounced memory difficulties, like misplacing things, repeating conversations, forgetting appointments and the worsening ability to recall recent events. A patients may also begin to have trouble with finding words, getting lost while driving or having trouble with judgment. This is caused by the worsening of cortical regions, like the frontal, temporal and parietal lobes. After a while, a patient becomes less able to manage his/her business and he or she loses the ability to perform activities of daily living. The progression of the illness is variable. It can be from several years to as many as 20 years, but eventually it will lead to total disability and death. The clinical diagnosis of Alzheimer’s Disease has a couple of criteria. The criteria are:

  1. Memory impairment and an impairment in at least one other cognitive domain

  2. Impairment in social and occupational function

  3. No other possible causes of the dementia syndrome

A clinical diagnosis can only be rendered when all other possible causes for the dementia have been rules out. It seems that the diagnosis of Alzheimer’s Disease is one of exclusion. Neuropsychological assessment is needed to confirm the presence and degree of cognitive deficits. Gradual onset of memory decline and progressive course are called probable Alzheimer’s Disease, atypical presentations when other etiologies may affect cognitive impairment are called possible Alzheimer’s Disease. The accuracy of the clinical criteria for probable Alzheimer’s Disease exceeds 85%, but a final diagnosis of the disorder can only be made when examining the density of plaques and tangles upon autopsy. Recently, there has been a revision in the proposed guidelines for the diagnosis Alzheimer’s Disease. The diagnosis of probable Alzheimer’s Disease now includes non-amnesic presentation of the illness (executive, language and visuospatial). There is also an addition of biomarkers which strengthen the certainty of diagnoses, like low AB42 in the cerebrospinal fluid, disproportionate atrophy in the basal, medial and lateral temporal lobe on MRI and elevation of tau proteins. Nowadays, Alzheimer’s Disease is no longer a diagnosis of exclusion. For the diagnosis of Alzheimer’s Disease it is also important to establish the presence or absence of cognitive impairment. When a person is moderately or severely impaired, the clinician will find enough information to arrive at a clinical impression. However, sometimes the cognitive deficits can be quite mild and difficult to detect by experienced clinicians. People who have a high cognitive reserve can employ other brain resources to mask certain deficits. The current treatments for Alzheimer’s Disease do not treat the underlying pathology of Alzheimer’s Disease. However, some recent studies suggest that treatments will be most effective in the earliest stages of Alzheimer’s Disease, before multiple systems degenerate.

Mild cognitive impairment

Research has found that the clinical manifestation of Alzheimer’s Disease occurs well before the manifestation of a dementia syndrome and a clinical diagnosis of the disorder. Mild cognitive impairment is an intermediate state between a normal cognitive state and a dementia. As mentioned in the chapter about mild cognitive impairment, the criteria for a mild cognitive impairment are a subjective memory complaint by the patient or somebody who knows him/her very well, intact intellectual function, objective evidence of memory impairment and no sufficient cognitive impairment to cause impairment in social or occupational function. In clinical settings, the rate of progression from mild cognitive impairment to dementia was 10-15% per year. However, in community settings, the progression to dementia among subjects with MCI is less. This means that mild cognitive impairment does not have to be confined to only an amnesic impairment, but it can also be defined by non-memory impairments. There are different types of mild cognitive impairment, that have been discussed in a previous chapter. The degree of impairment on both non-memory and amnesic measures is associated with the likelihood that individuals with mild cognitive impairment will progress to dementia instead of reverting to a normal state. Some studies have found that there is a difference in progression to dementia between people with amnesic and non-amnesic mild cognitive impairment, while other studies have found there is not so much different (both have a progression of approximately 52-56%). Some studies have found that impairment in more than one domain was most predictive in progression to dementia. The greatest likelihood of progression to dementia was in the multiple memory impairment group.

The clinical interview

A big part of a neuropsychological assessment is a detailed clinical interview with the patient and a collateral informant who is familiar with the patient’s daily life. It is most effective to interview the patient and the caregiver separately. This way, they can speak freely. Many informant are reluctant to share information about certain deteriorations in front of their relatives. It is important to initially gather information about the current cognitive difficulties that are experienced by the patient. It is also helpful to figure out whether the primary symptoms reported are primary those associated with memory or whether they are also represented by executive, language or attention disturbances. Memory impairment is an important feature of the disease, but individuals may initially present with language deficits or problems with executive function. Sometimes a person has cognitive resources to compensate for the initial deficits. However, the neurodegenerative process will continue until it progresses to a point where no successful compensation is possible. The first deficits will often be characterized by a language disturbance, like the inability to retrieve words. When the predominant symptoms in younger patients are language and executive dysfuntion, the clinician must consider the possibility of a frontotemporal dementia versus Alzheimer’s Disease. If there are predominant concerns with executive disturbances, cognitive slowing and attention disturbances, diffuse Lewy body disease must be considered.

It must also be determined if there has been a sudden onset of the symptoms or whether the cognitive disorder has a slowly progressive course, with gradual worsening of symptoms. In the first case, a non- Alzheimer’s Disease disorder can be considered, in the second case, Alzheimer’s Disease can be considered. The interview allows the clinician to determine the nature and extent of cognitive decline. The clinical interview gives the examiner the opportunity to determine the extent to which observed deficits interfere with occupational function. It also gives the opportunity to determine the effects of anxiety, depression and medical conditions on function.

Neuropsychological assessment

Neuropsychological batteries assess different aspects of neuropsychological function and the most sophisticated batteries assess executive function, learning memory, language and visuospatial skills. It is also good to have measures of processing speed and attention. When a clinician want to evaluate an individual for the presence of early dementia, he or she will probably give a measure of a list learning task. The advantage of this is that it provides an assessment of learning over several trials, which can evaluate the effects of proactive and retroactive inference and they provide measures of delayed recall. Recognition memory should also be assessed. These components are important in the evaluation of Alzheimer’s Disease. Difficulties with delayed recall are features of Alzheimer’s Disease, but not all Alzheimer’s Disease exhibit these features. It depends on the circumstances of evaluation for the choice of memory test. Most test are about reduced, delayed or cued recall.

There are also assessment of non-memory functions. The assessment of language function includes and evaluation of receptive and expressive language skills. There are different tests for word retrieval skills, like the Boston Naming Test. There are questions of semantic fluency and letter fluency. Elements of executive function tests are the ability to solve problems, plan, shift between cognitive sets and engage in concept formation. One of the measures for executive dysfunction is the Winsconsin Card Sorting Test. This is not a test for repeated testing. Sometimes it is important to distinguish between a perceptual disturbance from the inability to construct figures based on the perception, tests as the Hooper Visual Organization Test and Judgment of Line Orientation.

The neuropsychological tests should be administered to any older adult in which it is important to establish the absence or presence of cognitive deficits. Different patterns of neuropsychological deficits may help the clinician in diagnostic formulation and help the clinician to monitor progression and response to treatment. Sometimes there are cases that will remain difficult to diagnose, even with the most sensitive neuropsychological assessment. The clinician may conduct serial assessments in 6-9 months to track progression.

Access: 
Public
Differential Diagnosis of Depression and Dementia - Bieliauskas & Drag - 2013 - Article

Differential Diagnosis of Depression and Dementia - Bieliauskas & Drag - 2013 - Article

Studies have shown that depression in older adults has a prevalence rate between 3 and 14% in that population. One in 15 older adults may experience major depression over the course of one year. This late life depression is associated with negative outcomes, like disability, functional impairment, increased medical symptoms and increased use of health care services. Depression also has economic costs. Because of unexplained somatic complaints and functional impairments, older adults with depression use more medical services. One study showed that depressed older adults incurred 50% higher medical costs than non-depressed people of the same age. Most of these costs went to diagnostic visits, emergency room visits, pharmacy costs and primary care visits. A small part went to mental health care. Late-life depression can place a big burden on patients, the health-care system and caregivers. It is therefore important to assess the illness adequately and to treat the disorder.

Pseudodementia

Late-life depression can be accompanied by cognitive impairments. These changes look a lot like those associated with dementia. In the history, a psychiatric illness that mimicked dementia symptoms was referred to as pseudodementia. The cognitive symptoms of pseudodementia were assumed to be related to transient mood symptoms. Because of this, they were thought of as reversible with adequate psychiatric treatment. Because of this, the term reversible dementia was also used to describe depression-induced cognitive impairments. Wells was one of the first clinicians to popularize the term reversible dementia. He observed his patients with pseudodementia and saw that they had complaints of memory loss that were not apparent to their examiner. They also highlighted their failures and talked much about their disability. However, they functioned well and better than they said they can. This is different from patients with dementia, because patients with dementia often lack insight into the extent of their dysfunction and they tend to minimize their symptoms because of that. He also noted that patients with pseudodementia often responded ‘don’t know’ to close-ended questions, while they were able to provide detailed responses on open-ended questions. Patients with depression-related deficits also have recent and remote memory deficits. Wells also said that demented individuals often try to rely on calendars and notes, but depressed individuals do not attempt to compensate for their difficulties.

Pseudodementia was initially popular among clinicians, but now clinicians debate about the use of this term and the term is not really used anymore in current practice. The term was important, because it encouraged clinicians to evaluate every patient carefully and to look at alternate causes of cognitive decline other than dementia. However, this term has drawbacks. It implies a mutually exclusive process and this may lead the clinician to focus on whether someone is demented or depressed and the possibility that both conditions could be present is excluded. This term also implies complete reversibility. Research has found that in some older adults with depression and cognitive impairment, executive functioning did improve after an antidepressant treatment, but it failed to reach normal levels of performance. Other studies have also found that the treatment of depression may initially lead to improvements in dementia-related symptoms, follow-up shows that true reversibility of dementia is uncommon.

Depression as symptom of dementia

Although late-life depression can reflect a psychiatric disorder, it is more often the case that depressive symptoms are early manifestations of an underlying progressive dementing illness. High rates of depression and psychiatric symptoms are found across various neurodegenerative disorders, like vascular dementia, Parkinson’s disease and Alzheimer’s disease. Studies found that half of all individuals with cognitive impairment or diagnosed with dementia exhibited at least one psychiatric symptom. People with cognitive impairment or mild dementia most often have depression as a psychiatric symptom. In many studies, depressive symptoms appear to be highly prevalent in individuals with dementia. Depression can’t be solely attributed to a reaction to the disease itself. There is also no strong support for an association between severity of dementia and depression. Symptoms of depression can be equally prevalent across disease stages. There is a high comorbidity between depression and dementia and research has shown that depressive symptoms may be an early sign or risk factor for subsequent dementia or impairment. One study found that people baseline depression were more likely to develop dementia compared to non-depressed counterparts and they are also more likely to develop dementia earlier. It may be that depression is a risk factor for dementia, but it is also likely that depression is a behavioural manifestation of the dementia process itself. More research is needed into this subject.

Clinical assessment

Neuropsychologists play a big role in the assessment and treatment of dementia and depression. Many clinicians, like psychologists and neurologists often refer older adults for neuropsychological evaluation to better clarify a patient’s cognitive and psychiatric complaints. Neuropsychological evaluation can help diagnosis, management and treatment of the symptoms better.

It is important for the neuropsychological evaluation of a patient with depressive symptoms to gain qualitative and quantitative understanding of the symptoms. However, it is often difficult to assess depression in older adults. This can result from the fact that symptoms of depression are sometimes confounded by the effects of age and medical disorders. A loss of interest in activities and changed in appetite, libido and weight are common to medical illnesses, effects of aging and depression. For example, somebody may have a decline in social activities, but that should not mean that this person is depressed. He or she might no longer be able to drive and doesn’t have friends or relatives nearby. Also, a preference to stay home might be fatigue because of medical conditions rather than symptoms of depression. Older adults may also be more likely to underestimate their depressive symptoms. Older adults may have lower functional expectations for themselves, because of their increasing age and they may therefore dismiss their depressive symptoms due to the ageing process or declining health. Also, older adults are less likely to report dysphoric mood than younger people. Older people rather present vague symptoms, like fatigue or trouble sleeping. Given the fact that older adults are less likely to report dysphoric mood, clinicians need to look to subtle indicators of depression. These subtle indicators can be social isolation, headaches, changes in appetite, fatigue or delayed recovery from medical procedures. A careful evaluation must be performed. This basically suggests that all older adults who complain of cognitive problems should be screened for depression.

There are psychometric instruments that have been developed to screen for depression. Some of these are the Hamilton Depression Rating Scale (HDRS) and the Geriatric Depression Scale (GDS). The last scale specifically targets symptoms common to depression in older adults. There are also rating scales that have been developed specifically for use in patients with dementia. There are rule-out diagnoses to consider when a patient present with reported changes in both mood and cognitive functioning. Some disorders should be considered, like depression, bipolar disorder and anxiety. Symptoms as depression, apathy and irritability are also common across many of the dementia subtypes, like Alzheimer’s disease and Lewy body dementia. Changes in mood can also be associated with strokes. Many medications used to treat medical illness in older adults can cause depression-like symptoms. Beta-blockers and other drugs can affect both cognitive and mood functioning. Clinicians should also consider that depression may be a secondary reaction to a chronic medical illness. Digestive disorders and heart disease are also associated with an increased rate of depression symptoms. This is probably the case because people perceive a lack of control over medical symptoms.

Difference between dementia and depression

The psychiatric and cognitive symptoms associated with dementia can differ from those associated with a primary depression. Depression is usually associated with a more acute onset of symptoms (days or weeks), while the impairments associated with dementia can progress over years. This means that a gradual onset and progression of mood and cognitive symptoms will more likely reflect a dementing process and an acute onset is typically associated with depression. Also, depression often goes together with subjective cognitive complaints. Older people with depression are more likely to complain more about their cognitive difficulties than individuals with dementia. These complains may be out of proportion to the person’s actual level of functioning. A patient may complain of severe memory deficits, but still independently manage his or her finances. A lack of insight into symptoms is common in dementia and these people will more likely minimize their cognitive difficulties.

The presence of apathetic symptoms can be important when differentiating between dementia and depression. Apathy can be seen as a loss of motivation and is manifested as a lack of interest, low social engagement and an empty emotional response. Apathy can be a principal symptom of depression, but it can also reflect an independent syndrome and as distinct from the dysphoric symptoms of depression. Apathy is often seen as indifference and dysprhoric symptoms are often seen as guilt, sadness, hopelessness and self-criticism. Apathy is a feature in many neurodegenerative disorders, like Parkinson’s disease and Alzheimer’s disease. Apathy symptoms are more prevalent than dysphoric symptoms in people with Alzheimer’s disease. This means that apathy may be an early marker of preclinical Alzheimer’s disease and dysphoric mood may be more indicative of a depressive disorder.

There are also other depressive symptoms that are associated with dementia. Depressive profiles can differ between primary depression and dementia and because of this, a new set of diagnostic criteria has been proposed. The new criteria require the presence of three symptoms and these symptoms are similar to the symptoms in major depressive disorder. Social isolation and irritability are added to these. Decreased positive affect or a depressed mood is required. These symptoms don’t have to be present every day (like they are in primary depression). Clinicians should also take the age of onset of depressive symptoms into consideration. There are difference between early-onset and late-onset depression, so these might be distinct entities. Late-onset depression has a first onset between 45 and 60 years of age. Pathogenic brain contributions are different for these two different onsets. Some researchers suggest that there are cognitive difficulties associated with an initial onset of depression and that these are based on neurological disease. Some studies have found that high-intensity lesions and atrophy have a connection to late-onset depression. Others have found a correlation between findings on neuroimaging and cognitive changes with depression. Loss of interest has also been found to be greater in late-onset depression. So, depression with a late age of onset is more likely to be associated with neuropathology or the early stages of dementia. When it comes to sleep patterns, depression and dementia can also differ. Alzheimer’s Disease is associated with poor sleep and with frequent night awakenings. The onset sleep is also later and goes together with difficulty awakening in the morning. Older adults with depression have difficulty falling asleep, wake up early in the morning and have an impaired sleep continuity. So people with depression have difficulty staying asleep in the morning, while people with Alzheimer’s disease have difficulty waking up in the morning. Increased REM sleep is more characteristic of depression than dementia and this might help distinguish depression from dementia. However, clinicians don’t have this sleep information ready available. They first have to request a formal sleep study.

Neuropsychological profiles

Neuropsychological testing is important and may help distinguish dementia from depression. The cognitive changes in dementia are more severe than those in depression. So there is a difference in severity, but there are also qualitative differences. Cognitive symptoms associated with dementia are progressive, but cognitive deficits related to depression should stabilize or improve with good management of the psychiatric symptoms. So there need to be repeated neuropsychological evaluations. Other differences are those in effortful processing. Cognitive changes in depression lead to difficulties on tasks that require a high degree of cognitive resources, but performances on tasks that are more automatic require less effort the complete. The deficits in dementia result in the impairments that are independent of the degree of effortful processing. This hypothesis might be useful, but it may be overly generalized and has not been supported fully by research.

Late-life depression is associated with cognitive deficits in the domain of attention, memory and executive functioning. Especially the executive functioning difficulties are most prominent in depression. These difficulties can mediate the cognitive difficulties found in other domains, like memory. Alzheimer’s disease is characterized by a prominent memory deficit. Depression and dementia can both impact performance on immediate and delayed memory tasks, but delayed retrieval tasks can differentiate between the two. Alzheimer’s disease goes together with fast forgetting of information and this results in poor delayed recall and recognition performance. Alzheimer’s Disease affects the hippocampus and this area is critical to memory encoding and storage. Depressed people may have difficulties with delayed recall, but their performance can improve when they are given cues. Research has shown that old people with depression perform poorly on list learning tasks, but when they were given semantic cues, their memory improved to normal levels. These cued recall tasks did not improve the memory of people with dementia and so these tasks can be used to distinguish Alzheimer’s Disease from depression.

Recognition tasks can also help distinguish between dementia and depression. Recognition tasks minimize the need for strategic and effortful retrieval and depressed people show adequate performance on these tasks, while patients with Alzheimer’s Disease do not. Serial position effects can also be informative. People with Alzheimer’s Disease show poorer overall recall on word lists compared to depressed people. Alzheimer’s Disease individuals recalled words from the end of the list better than the words from the beginning of the list. This is consistent with difficulty retaining information in memory over time. Depressed people recalled words from the beginning and end of the list better than words from the middle of the list. This poor middle-list performance distinguishes depressed people from healthy ones. There are also some other differences between these two. Patients with Alzheimer’s disease have more difficulty performing dual tasks than patients with a depression. Dementia is also more associated with impairments on task of naming, visuopercentual processing and ideomotor praxis (inability to mimic hand gestures) than depression is. So, dementia and depression can differ in quantity and quality of cognitive deficits. Alzheimer’s Disease is typified by a prominent memory disturbance and also with deficits in praxis and language. Depression shows a frontal mediated pattern deficit, that leads to executive functioning deficits which can have its effects on other cognitive domains, because of the lack of initiation or strategic processing.

Access: 
Public
Accurate Assessment of Behavioral Variant Frontotemporal Dementia - LaMarre & Kramer - 2013 - Article

Accurate Assessment of Behavioral Variant Frontotemporal Dementia - LaMarre & Kramer - 2013 - Article

Frontotemporal dementia (FTD) is a collective name for three neurodegenerative syndromes. Behavioural variant frontotemporal dementia (bvFTD) is one of these. First clinicians thought it to be rare, but now they know that it is equally as common as Alzheimer’s Disease (AD) in individuals under the age of 65 and it is also the third most common dementia after Alzheimer’s disease and dementia with Lewy bodies (DBL). The estimates of the prevalence of FTD vary and studies from the United States and United Kingdom estimate an occurrence at around 3.3-3.5/100000 in individuals between 45 and 65 years of age. Age of onset is often before the senior years, but onset ranges from the 30s to 90s. usually, the duration of FTD ranges from 8 to 11 years. FTD is expressed as three main variants. BvFTD is characterized by early changes in personality and behaviour. This is the most common phenotype of the disease and accounts for approximately 70% of the clinical expression of the disease. Therefore, bvFTD is the subject of this article. The other two are primary progressive aphasic syndromes. The first one is the semantic variant (svPPA) and it is associated with the loss of word knowledge and the second one is the nonfluent variant (nfPPA) and is characterized by early disturbances in motor speech output and the loss of grammatical structures of language. Many studies find a male bias in bvFTD and svPPA and a female bias in nfPPA.

Signs and criteria of bvFTD

The earliest signs of disease in bvFTD are subtle personality and behavioural changes that become more pronounced as time goes on. Some of these are apathy, reduced emotional response, changes in belief and personality, impaired in personal awareness and poor judgment. The changes are often dramatic and they result in the dissolution of the individual’s former self and relatives and partners no longer recognize their loved one. Some patients may begin to make impulsive decisions or actions, like shoplifting, assaulting others or driving recklessly. They might become cold and self-centered and don’t respond to the needs of others anymore.

The diagnosis of bvFTD has most often been made using certain criteria, but advancements in our understanding of the disease has led to the development of new criteria. Now, diagnosis of possible bvFTD is based solely on clinical presentation. Patients must meet at least three of the six criteria: early apathy, early behavioural disinhibition, early stereotyped or compulsive behaviours, early loss of sympathy, hyperorality or dietary changes and a neuropsychological profile suggesting deficits on tasks of executive function, while relatively sparing the memory and visuospatial function. To meet criteria for probable bvFTD, one must meet the criteria for possible bvFTD, exhibit functional decline and show evidence of temporal and/or frontal atrophy.

Neuroanatomy and pathology

A recent study suggests that initial degeneration occurs in paralimbic structures, like the anterior cingulate cortex, dorsal anterior insula, frontoinsular region and lateral orbitofrontal cortex. These structures have been implicated in human social function and awareness of the self and they are part of a neural network thought to play a role in the decoding of emotional salience of a stimulus, in order to facilitate appropriate action. When the disease progresses, neurodegeneration occurs in many areas of the frontal and temporal lobes. BvFTD is caused by abnormal aggregation of protein in the brain, this is called frontotemporal lobar degeneration (FTLD). The two most common pathologies associated with bvFTD are FTLD with tau-positive inclusions (FTLD-tau) and FTLD with TDP-43 positive inclusion (FTLD-TDP). Under normal conditions, TDP-43 and tau play important roles in neuronal cells structure and function. However, under pathological conditions, these proteins aggregate and they are associated with cell death. New findings of the past ten years have demonstrated links with diseases not historically believed to be associated with changes in behaviour and cognition. FTLD-tau is associated with frontotemporal dementia, parkinsonism and progressive supranuclear palsy (PSP).

Genetics

Approximately 30-40% of bvFTD cases are genetic in nature. At this time, we know on which three chromosomes genetic mutations that cause familial FTD can be found (three, nine, seventeen). The greatest proportion of familial cases comes from people who have mutations on two independent, but extremely close locations on chromosome 17. One is caused by mutations in the microtubule-associated protein (MAPT) gene. The MAPT codes for the protein tau is a major pathological subtype of bvFTD. Also, the growth factor progranulin is associated with bvFTD. All three variants of FTD may occur in familial forms of the disease, but some variants are more likely to be expressed than others. For example, PGRN mutation carriers develop symptoms characteristic of bvFTD.

Differential diagnosis

Diagnosis of bvFTD remains challenging. BvFTD is sometimes misdiagnosed as early onset AD. This is not weird, because AD is the most prevalent dementia syndrome. Many symptoms of these two diseases overlap, like executive function. People with neurodegenerative motor syndromes may also show symptoms consistent with a diagnosis of bvFTD. Huntington’s disease also mimics many of the psychiatric and behavioural disturbances seen in bvFTD. People with bvFTD may also be misdiagnosed with a late-onset psychiatric disturbance. The symptoms of euphoria, poor judgments and disinhibition can mimic the symptoms of mania and apathy and eating disturbance might be seen as depression. In one study, of the patients with bvFTD, 51% of patients had received a prior diagnosis of a psychiatric disorder (schizophrenia, major depression), compared to 23% of patients with Alzheimer’s disease. This suggests that the symptoms of bvFTD are misunderstood by mental-health-care providers. Accurate differential diagnosis is important, because treatments must match the appropriate diagnosis. Scientists are busy developing specific, disease-modifying therapies for FTLD and they focus on the major proteins that are involved in the pathogenesis of the disease. Researchers are trying to manipulate tau and they are also trying to modify PGRN and TDP-43 levels. Researchers must test the efficacy of these medications by using homogeneous samples in clinical trials. There are no methods for determining pathology prior to autopsy, so predicting pathology antemortem remains a key challenge.

Neuropsychological literature

A number of significant issues contributes to discrepancies in research data (the lack of a universal diagnostic criteria, small sample sizes, lumping the three clinical variants together). These issues can also arise due to test selection and interpretation issues. For example, the impaired performance on tests can be due to factors that are beyond what the test is meant to measure. The behavioural manifestations of the disease itself, like poor motivation, can contribute to variability in cognitive performance scores. Our understanding of the neuropsychology of bvFTD lies within the context of research seeking to improve differential diagnosis between neurodegenerative diseases. Mostly, patients with bvFTD are compared to patients with AD.

Patients with AD exhibit severe verbal and visuospatial episodic memory deficits, while patients with bvFTD show a relative preservation in their episodic memory. One study found that serial-order recall was more common in people with bvFTD than in those with AD. The most salient difference between patients with bvFTD and those with AD is that bvFTD patients tend to retain information over delays, while patients with AD forget more rapidly. Visual memory is also relatively spared in patients with bvFTD. However, these patterns of memory performance are not specific to bvFTD. Parkinson’s disease and PSP may also show similar patterns. People with bvFTD have reductions in spontaneous speech and this decreased verbal output can progress to complete mutism. Other speech disorders can also occur, like verbal stereotypes and automatic speech. There have been not so many studies that have examined differential language patterns between bvFTD and other diseases.

One study did find that people with AD scores lower on semantic fluency (category fluency) than phonemic fluency (letter fluency), while people with FTD performed poorly on both types of fluency. Some studies have found that patients with bvFTD have visuo-constructional deficits on par with AD when the figure is complex, but most studies have indicated that visuo-construction and visual perceptual skills are better preserved in patients with bvFTD than in patients with AD. Difficulties for patients with bvFTD can arise when the task relies much on top-down control of spatial processing. There is much discrepancy in the research on attention and executive functions in bvFTD. Some studies find impairments in these domains, while others do not. Some researchers expect to see executive deficits manifested later in the disease. Some even say that certain subtypes are less likely to show executive function deficits. One reason for the inconsistent findings is the fact that executive functions are a poorly defined construct. So some studies have broader conceptions of executive functions than others. Many studies did find that people with bvFTD perform faster on measures of executive function (like the Stroop Inhibition task) than patients with AD, but they make also more errors. This means that they have an inbalance in their ability to accurately make speed/error trade-offs. The dorsolateral prefrontal cortex degenerates both in AD and bvFTD. This may occur at different stages in disease course. Because of this, people with bvFTD may show flat affect, more perseveration and reduced initiative than patients with other neurodegenerative disease. Other studies have found poor social judgment in people with bvFTD. Researchers have also found that people with bvFTD have less self-awareness regarding their current personality and behavioural deficits, compared to patients with AD. This may be due to the emotion-processing deficits that people with bvFTD have. Basic emotion processing remains intact, but more complex forms of emotion (embarrassment, recognizing emotions in others) show deficits.

Clinical assessment

An evaluation of bvFTD should include a clinical interview, assessment of social and emotional function, neuropsychological assessment and informant based measures. Cognition can be relatively preserved in the early stages of the disease, so the informant report, history and observable behaviour seen throughout assessment will be very helpful information. A well-constructed clinical interview with a good informant is critical. The patients often lack insight into the emotional, social or behavioural issues that are seen by their informants and they also deny problems. Sometimes, the informant doesn’t feel comfortable to speak freely when the patients is around, so a clinician should consider conducting a separate interview. During the interview, a couple of subjects need to be covered. One of these is the onset and progression of the disease. BvFTD is an insidious disease that may begin many years before changes become obvious. Also, because the age of onset of bvFTD is in the late 50s, some people might interpret the personality changes as mid-life troubles. Abrupt onset changes in personality and behaviour are less likely to be bvFTD. During the interview, one must also look at the nature of change. There are six things a clinician needs to figure out:

  • Early behaviour disinhibition: does the person show socially unacceptable behaviour? Has the person become socially, cognitively or behaviourally disinhibited?

  • Early loss of empathy/sympathy: does the person make insensitive comments?

  • Early apathy: does the patient show a loss of interest, drive or initiation of behaviour?

  • Compulsive/stereotypes behaviour: people with bvFTD can manifest complex compulsions, like checking rituals or hoarding.

  • Neuropsychological profile: does the patient seem to have trouble doing two things at once or completing complex tasks?

  • Hyperorality or dietary changes: does the patient consume certain foods/drinks in more quantities than before? Does the patient take up another diet? Weight gain is common in bvFTD.

During the interview, the clinician also needs to find out more about the potential family history of the disease. 30 to 40% of all people with bvFTD have a strong family history of the disease. However, it is often difficult to elicit clear family histories. Some may have a vague recollection that one of their grandparents was senile. However, if the family history reveals that a family member exhibited changes in social behaviour and personality after the fifth decade of life or who had symptoms of motor disorder, these are clues that the individual may have a genetic form of the disease. It will also be helpful if the patient has had neuroimaging. A report of the scan can best be used with other information from the interview, to come up with a diagnosis.

Cognitive assessment and behaviour observation

The writers of this text find that a short battery (1 to 1.5 hours) that examines all major cognitive domains is a quick and useful way to help aid differential diagnosis without overtaxing the patient. The neuropsychological profile of a person with bvFTD is one of spared visuospatial and language function and relatively better performance than people with AD on tests of semantic and episodic memory. The writers recommend executive function tests that elicit and quantify performance errors. In the centre of the writers, after the neuropsychological evaluation, the examiners of the centre complete a brief behaviour-rating scale where patients are rated on a scale ranging from none to severe on a couple of behaviour. Some of these behaviours are agitation, lack of social engagement, impulsivity, fluctuation levels of attention, motor stereotypies and inappropriate behaviour. inappropriate behaviour and lack of social engagement discriminate between patients with bvFTD and AD. The inclusion of informant-based measures will give more (sometimes more reliable) information. According to the writers, it is a good idea to include a neuropsychiatric inventory which the informant needs to fill in about the patient. Scales of emotional responses, measures of social function, measures of emotional recognition and social norms questionnaires should be included, so the level of emotional and social functioning of the patient can be assessed.

Access: 
Public
Vascular Cognitive Impairment - Paul, Lane & Jefferson - 2013 - Article

Vascular Cognitive Impairment - Paul, Lane & Jefferson - 2013 - Article

When people get older, the risk of cerebrovascular disease increases. Approximately 70% of individuals over the age of 70 exhibit evidence of vascular lesions on MRI-scans. These lesions can have different clinical profiles. Some small lesions can result in little to no cognitive impairment and other lesions are so severe, that they result in clinical dementia. Vascular cognitive impairment was introduced as a term to describe all forms of cognitive impairment causes by cerebrovascular disease. The type of impairment associated with vascular cognitive impairment depends on the location and amount of damaged tissue. This in turn influences the severity of behavioural, cognitive and psychiatric features. Early identification of vascular dementia is important, because many of the risk factors for vascular disease are modifiable. At the mildest end, with vascular cognitive impairment is called a vascular cognitive impairment no dementia (VCIND). At the severe end, with vascular cognitive impairment is referred to as vascular dementia and it is one of the more common types of dementia among older adults after Alzheimer’s Disease. Approximately one-third of individuals will develop dementia within one year after a stroke. When a stroke affects a very large vessel, or is strategically located, the result is likely consistent with the concept of dementia due to stroke. Clinical symptoms with associated with stroke are very variable and depend upon the area impacted. Impairment due to large vessel or strategic stroke is most commonly tied to the concept of vascular dementia, but it is not the most common expression of the disease. Vascular dementia has a more insidious onset and a slow and gradual decline. Mixed dementia between vascular cognitive impairment and vascular dementia is common, but it is controversial in the field.

Clinical presentation

With vascular cognitive impairment, clinical preconceptions of disease expression and progression are not realized, because heterogeneity is the rule. Patterns of abrupt onset and stepwise decline in function are less common than a slow and progressive disease course. With this disease, executive dysfunction may predominate, but the neuropsychological presentation will be driven by the extent of diffuse and focal vascular injuries in the brain.

Vascular cognitive impairment, no dementia

VCIND refers to vascular lesions that can be seen on MRI, but that cause impairment too mild to impact activities of daily living. The most common types that can be visualised on MRI are lacunes (small cerebrospinal filled cavities in the white matter) and subcortical hyperintensities (vascular-related damage). It is not uncommon for a person to have this type of vascular damage and show normal neuropsychological abilities. VCIND may be a prodromal stage for vascular dementia, VaD. Because of this, modifiable risk factors may be important in reducing the progression of the disease. One study showed that half of the VCIND cases progressed to dementia over a 5-year period in time. People who have VCIND and frontal white matter hyperintensities are less likely to revert back to normal cognitive function after 1 year as compared to people with VCIND who do not have frontal white matter hyperintesities. Modifiable risk factors may play an important role in determining the progression of VCIND to VaD. The current pharmacological treatment options for VaD are relatively ineffective at arresting disease progression, so there is a need for early identification and clinical intervention. There is not a consistent neuropsychological profile that is predictive of advancement from VCIND to VaD, but people with VCIND often display poor performance on tests of cognitive flexibility, psychomotor speed and learning. VCIND may also increase the incidence of depression, but it is not known if vascular damage is the cause of depression or a result of the deficits.

Vascular dementia

VaD results from extensive white matter lesions and lacunar infarcts due to small vessel disease, it can also result from one or more strokes to the main cerebral arteries, or the combination of the two. The most common impaired domains of function in VaD are learning, delayed memory, executive function, with intact recognition memory. The deficits in executive function are most typically found on tests of verbal fluency, response inhibition and mental flexibility. Episodic memory deficits are found on tests of recall and list learning. Recognition may stay intact if the structures of the medial temporal lobe are not damaged. Depression is the most common behavioural feature associated with stroke. 20% of people with strokes also exhibit depression. The strongest predictor of depression is reduction in the ability to carry out activities of daily living. However, this may be confounded by stroke severity. Increased depression is associated with greater cognitive impairment and increased mortality. Depression can’t explain the cognitive deficits found in patients with VaD. There are a couple of VaD criteria proposed. The most used criteria is memory deficit. The criteria for VaD from the DSM are:

  1. Multiple deficits manifested by both

    1. Memory impairment

    2. At least one of the following:

      • Apraxia: motor activity impairment

      • Aphasia: language disturbance

      • Disturbance in executive functions (planning, organizing)

      • Agnosia: not recognising objects, despite intact sensory function

  2. The deficits just mentioned cause impairment in occupational and social functioning and the functioning must show a decline from previous functioning

  3. Focal neurological signs and symptoms or laboratory evidence for cerebrovascular disease

  4. The deficits must not occur exclusively during the occurrence of a delirium

Risk factors for VCI

There are a couple of variables associated with increased risk for stroke. Strokes can occur in younger people (with sickle cell anemia), but they are most common among older people. The greatest risk factor associated with VCI is age. Other unmodifiable risk factors for stroke are male sex, atrial fibrillation, weight, race (African American) and ethnicity (Latino). There are also a couple of deterministic genetic factors that increase the risk of vascular disease. One of these is cerebral autosomal dominant arteriopathy with subcortical infarcts leukoencephalopathy (CADASIL). CADASIL is a rare autosomal disease and it is associated with a Notch3 defect that causes infarcts in the deep white matter, brain stem and basal ganglia. The average onset of a stroke is 45 years, but many individuals with CADASIL will experience migraine with aura with an average onset at age 30 years. People with CADASIL develop dementia by the sixth decade of life and they die by the seventh decade. The cognitive deficits of CADASIL patients impact organizational abilities, executive functions and attention. A susceptibility gene for vascular disease is angiotensinogen. This gene is involved with the development of subcortical ischemic disease. Cerebrovascular disease is the underlying cause of VCI, so the risk factors related to the development of VCI overlap with those related to cardiovascular disease. The improvement of risk factors underlying overall cardiovascular health lowers the risk of stroke. Studies have shown that stopping with smoking and lowering of hypertension result in reduced stroke risk in advanced age.

Differential diagnosis

When a clinician evaluates older adults for VCI, he/she may considerate other diagnoses. Some of these are Alzheimer’s Disease, Lewy body dementia, frontotemporal dementias and normal pressure hydrocephalus (NPH). NPH is quite similar to VCI, as both conditions share frontal symptoms, but NPH more frequently includes urinary urgency and gait disturbance. When these two are present, the likelihood of NPH as the appropriate diagnosis increases. Frontotemporal dementia presents with more unique symptoms than VCI, like aphasia or personality abnormalities. The age of onset for VCI is often older than what is typical for frontotemporal dementia. It is difficult for the clinician to rule out Alzheimer’s Disease. First, clinicians thought that the neuropsychological patterns of Alzheimer’s Disease and VCI and the decline of these were disease specific, but this position has been challenged. Autopsy shows that AD and vascular neuropathology frequently coexist. This means that many patients exhibit some degree of shares disease presentation during life. It is still not clear whether both conditions develop independently or whether one condition develops first, followed by the other.

Clinical evaluation

The model of vascular-mediate brain injury has evolved more than other neurodegenerative conditions over the last few decades. Beliefs about the course of decline, the neuropsychological pattern and the utility of MRI-defined vascular burden have shifted the approach and accuracy of the neuropsychological evaluation. The clinical evaluation should follow a patient-oriented approach. A clinician also needs personal, medical and neuropsychological information.

Interviews

The clinical interview is important for the assessment for vascular disease. Many patients have good insight into their cognitive deficits, but not all patients have full insight. Patients need to pay attention in order to describe their symptoms. Often, patients will confuse concepts or misinterpret the MRI report regarding cortical versus subcortical vascular disease. The access to medical records will clarify these issues, but some clinicians work in independent practice and the records may arrive after the patient has been evaluated. During the interview, a clinician can also observe language skills and potential aphasic abnormalities. The clinician can also see if the patients can recall information correctly. Sometimes patients may describe memory failure as a tip of the tongue phenomena, rather than outright amnesic failure, but during the interview, the clinician can see whether this is the case or not. During the interview, the clinician can also extract apathy and mood constructs from the patient.

Clinicians have difficulty to differentiate between a progressive and stepwise decline. The VCI literature has characterized the decline in physical and cognitive status associated with stroke as stepwise, while the insidious and progressive decline is part of Alzheimer’s Disease. When the partner or family describes a repetitive pattern of sharp decline followed by stabilization, the stepwise pattern was confirmed and vascular etiology would be considered more likely than a diagnosis of AD. This description of decline is appropriate for many infarcts, but the pattern does not hold for small vessel disease. Clinicians should not rely on the course of decline as a pathogenic sign of vascular disease and they need neuropsychological data and neuroimaging results.

Neuropsychological assessment

Some screening measures, like the mini-mental state exam, lack sensitivity to vascular-related impairments. The Montreal Cognitive Assessment (MoCA) was introduced to provide more coverage of executive processes in the screening of dementia. The MoCA is not specifically developed for VCI and it is unclear whether the task demands capture mild to moderate cognitive impairments associated with cerebrovascular disease in a good way. A couple of years ago it was suggested that a brief 30-min and a more comprehensive 60-min neuropsychological battery for VCI should be done. The 30-min battery is limited to psychomotor speed, verbal memory and verbal fluency. The 60-min battery represents all major cognitive systems like attention, working memory, processing speed, language and mood. For memory, it is critical to use measures that capture learning efficacy across trials, recognition and delayed retention. This can help to differentiate between AD and VCI. It is also recommended to measure both letter and category fluency, because people with VCI score poorer on letter fluency, while people with AD score poorer on category fluency.

Neuroimaging

Sometimes, it is tempting for clinicians to rely too heavily on neuropsychological data alone to determine the etiology of cognitive impairment. It will be the most problematic to the clinician in the case of VCI. However, when there is no obvious data present of neuropsychological impairment for VCI, it is important that neuroimaging results are integrated into the case conceptualization to reach a more whole diagnosis. The neuroimaging abnormalities that are associated with a stroke can be identified on high-powered MRI, using a fluid-attenuated inversion recovery (FLAIR) scan. Vascular disease on these images is characterized by lacunes in white and subcortical grey matter. Neuropsychologists are often not trained to review films independently, so the degree of vascular burden must be gleaned from the radiologist’s report. However, this has some problems, because radiologists do not use standard metric systems for determining the level of pathologic burden as neuropsychologists do. Cerebrovascular disease is common among the general population after age 65 years. So, this may cause some difficulties for the MRI interpretation, because there might be some vascular burden to be seen on the MRI-scan, but this might not be sufficient enough the account for the cognitive difficulties.

Access: 
Public
Movement Disorders with Dementia in Older Adults - Tröster & Browner - 2013 - Article

Movement Disorders with Dementia in Older Adults - Tröster & Browner - 2013 - Article

The most common dementias associated with movement disorders in old age are dementia with Lewy bodies (DLB), Parkinson’s Disease (PD) dementia (PDD), corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP). These different conditions can be grouped according to their characteristic neuropathological characteristics as synucleinopathies (DLB and PDD) or tauopathies (CBD and PSP). Clinical neuropsychological test findings by themselves are not diagnostic and it is often hard to between the features of PDD and DLB, even if subtle differences occasionally emerge. CBD and PSPS have also symptom overlap and it is also difficult to distinguish these two. However, neuropsychological evaluation that weighs test results, interview formation about disease course, neuroimaging findings, comorbidities and motor and non-motor symptoms can help ruling out or supporting a specific diagnosis. When a patient with a movement disorder and dementia is referred for neuropsychological evaluation, the issue is often one of facilitating differential diagnosis and determining if other factors (medication, depression) are producing cognitive compromise. Other issues are patient selection for treatment, characterization of deficits to determine interventions and documenting deficit progression.

Epidemiology

There is not much agreement among scholars about the prevalence of Parkinson’s Disease or Parkinson’s Disease dementia. It all depends on the diagnostic criteria, sampling and methods used. The writers of this text say that dementia incidence is about 3% for persons with PD younger than 60 years and 15% for persons with PD older than 80 years. Low education and advancing age have been associated with increased dementia risk in PD, but there are also some other factors. DLB is said to be the second most common cause of dementia and it counts up to 20% of the cases coming to autopsy. According to a review of six different studies, the prevalence of DLB ranges from 0 to 5% among the general population and from 0 to 31% among dementia cases.

The incidence and prevalence of CBD have not been widely studied. Many studies show different prevalence rates. Dementia and neurobehavioral abnormalities were thought to be rare CBD, but now they are accepted to be a common problem in this disease. One study mentioned that only 19% of 36 patients had slight generalized cognitive impairment, but another study stated that among 13 pathologically confirmed cases, 69% had dementia at presentation. H1/H1/ tau haplotype is identified as heightening susceptibility to CBD and PSP, but no clear genetic etiology has been identified. The population prevalence of PSP ranges from 3 to 6 per 100000 and a recent Russian study states that the annual incidence of PSP is estimated at 5 per 100000 in persons older than 50 years. Incidence and prevalence of PSP is not strongly associated with genetic or demographic risk factors, except older age. A recent study observed dementia in 57% of people with PSP.

Clinical and neurological presentation

There have been some separate criteria proposed for PDD and DLB. An important feature differentiating DLB and PDD is the time of onset of dementia in relation to onset of motor signs. A diagnosis of DLB is made, when neurobehavioral symptoms precede or occur within the first 12 months of the motor signs. A diagnosis of PDD is made, when cognitive symptoms have their onset more than 12 months after the onset of parkinsonism. Logically, Parkinson’s disease dementia requires that a prior diagnosis of Parkinson’s disease has been made. The criteria for PD diagnosis are the presence of a parkinsonian syndrome. This is evidenced by bradykinesia (slow movement), muscular rigidity, resting tremor, postural instability, visual, vestibular or cerebral dysfunction. Also, for the diagnosis of definite PD, at least three supportive features are required: progression of symptoms, unilateral onset, persistence of symptom asymmetry, excellent response to levodopa, levodopa response sustained for 5 years, dyskinesia or a clinical course over 10 years. PD becomes most often symptomatic during the sixth decade of life, but young onset can occur. The most common initial cognitive complaint in PDD and DLB patients involve memory complaints. 67% of PDD and 94% of DLB patients initially complained of memory problems. Patients also may initially complain about word-finding problems, keeping up with conversation due to slowness of thought, financial management, problems with concentration and apathy. People with PDD have problems with day-to-day repair tasks with which they were previously facile. DLB patients also complain of hallucinations, visual distortion and sleep behaviour disorder

Pathological confirmed CBD can have heterogeneous clinical presentations. Corticobasal syndrome (CBS) is characterized by the core motor and cortical features of CBD regardless of etiology. The term CBD is reserved for neuropathologically distinct CBD regardless of clinical presentation. CBD onset is often in the sixth decade of life and after the diagnosis, the mean time to death is about 7 years. CBD can present with either motor or cognitive dysfunction. Initial complaints include stiffness, clumsiness or jerkiness or an arm and sometimes clumsiness of a leg. The motor features of CBD include asymmetric, progressive, akinetic-rigid parkinsonism of gradual onset, minimal response to levodopa, hand, limb and speech apraxia (movement). Cortical signs in CBD are cortical sensory deficits, alien hand syndrome and ideomotor apraxia. Alien hand syndrome is the feeling that your limb(s) is/are not your own and that they move involuntary.

PSP has some of the same features as CBD and frontotemporal dementia. Signs of PSP may be evident as early as age 40, while formal diagnosis typically occurs after age 60 and there are very high incidence rates after age 80. There are no effective pharmacological or neurosurgical treatments available for patients with PSP and after diagnosis, the patients survive 5 to 10 years after diagnosis. The criteria of possible PSP require a gradually progressive disorder beginning at age 40 or later, postural instability in the first year of disease, vertical supranuclear gaze palsy and other diseases that could explain these features need to be excluded. Probable PSP requires postural instability, vertical supranuclear gaze palsy, and falls in the first year of onset. The earliest symptoms of PSP are imbalance, like falls, worsened postural reflexes and dysarthria (motor speech problems). There is a poor hand-eye coordination, and because of this, an early symptom of PSP is sloppy eating. Symmetric bradykinesia is also common. Also, there is a slowing of thought and gaze. There are no universally accepted clinical subtypes or categories of PSP. All but 15% of the cases could fall in the traditional PSP syndrome, and the rest falls in PSP associated with PD-like symptoms.

Neuropathology

PD has been defined by neuronal loss and Lewy bodies (LB) in the substantia nigra. But these patients also have a presence of LB and Lewy neurites (LN) outside the substantia nigra. One study found three phenotypes of PD patients: a group with early, prominent dementia and akinetic-rigid PD (this corresponds clinically to DLB), a group of older PD patients (onset after 70 years) developing dementia in 3-10 years (corresponds to PDD) and a younger PD group (onset before 70 years) in which dementia occurs late in the disease (after 10-15 years). Many people with DLB have amyloid plaques at autopsy, while in PDD this is less. Both PDD and DLB involve dysfunction of the dopaminergic and cholinergic systems. The pathological features of CBD include ballooned neurons, which are mostly found in frontoparietal cortex, but they are also found in the amygdala, insular cortex and anterior cingulate. The frontal and frontoparietal cortices show asymmetric atrophy. There are also tau-containing neuronal inclusions in the cortex. The substantia nigra shows cell loss and there is neuronal loss in many systems. In PSP, the whole substantia nigra is compromised and there is a dopaminergic depletion in the caudate and putamen. There are also neurofibrillary tangles in the brain stem and basal ganglia.

Neuroimaging findings

For patients with PDD, studies have shown an association between dementia and medial temporal, neocortical and amygdala atrophy. Studies show also greater parietal, temporal and occipital neocortical atrophy in DLB than PDD. Some studies show there is a greater PIB uptake (beta-amyloid deposition, chapter about Alzheimer) in DLB, but not PDD. Studies also show that posterior cerebral blood flow and glucose metabolism is especially reduced in DLB and PDD. In patients with CBD, MRI reveals cortical atrophy, especially frontoparietal. Other findings show dopaminergic abnormalities in CBD. MRI findings of PSP patients show midbrain atrophy. Cortical atrophy also occurs and frontal atrophy is linked with executive dysfunction.

Neuropsychology

Performance on simple attention tasks is usually preserved in PD, but as the disease progresses, impairments can even be found on cued attention tasks. Early on in PD, there are impairments in working memory tasks and these deficits progress in PDD. Complex attention tasks (like the Stroop task) are more likely than simple tasks to elicit attention impairment in PDD and DLB. Planning is often slowed or inaccurate in PD, these patients are also found to be slow in conceptualization and they have difficulty to switch between two different sets of stimuli. People with PDD have more impaired verbal fluency than PD patients, but verbal fluency is similarly impaired in DLB and PDD. Visual confrontation naming is preserved in PD. There is a retrieval deficit in PD. Recognition is also not necessarily intact in PD. Semantic encoding might also be deficient in PD. DLB and PDD show similar memory impairments. However, DLB shows poorer recall and more rapid rates of forgetting, PDD makes more perseverative errors during list learning. There are comparably severe deficits in PDD and DLB that have been observed on different visuospatial and constructional tasks. These visuospatial and constructional tasks deficits are even found in mild DLB. They show deficits in copying of figures (you can see a picture of this on page 342 of the Neuropsychology book).

Depression is often undertreated in PD. Anxiety and depression often go unrecognized by clinicians treating PD. It is therefore important to screen for neuropsychiatric conditions. Depression is common in PD and it occurs in about half all patients. Depression prevalence estimates for PDD and DLB are not really available. One study found that major depression occurs in about 13% of patients with PDD and in about 19% of patients with DLB. About half the patients with PD have symptoms of anxiety, and 75% of those patients with PD and depression may have a comorbid anxiety disorder. However, the prevalence of actual anxiety disorders in PD ranges from 5% to 40%. Almost 20% of PD patients had generalized anxiety and 20% had a social phobia. A considerable number of PD patients have obsessive compulsive disorder. Anxiety occurs in two-thirds of patients with DLB. Psychosis is common in PDD and DLB, but more common in PD. Hallucinations occur in 76% of DLB and 54% of PDD and delusions occur in 57% of DLB and 29% of PDD. They are of similar quality in both patient groups.

Patients with CBD have marked impairments working memory (digit span backward). Patients with CBD have also executive dysfunction. The aphasia in CBD is most commonly non-fluent. The language problems in CBD is phonologic. Verbal fluency is impaired, because of executive demands on those tasks. Semantic memory tasks like conceptual matching and expressive vocabulary is relatively preserved. Apraxia is often ideomotor, patients most often have difficulty demonstrate the use of tools. Memory impairments in CBD are encoding and retrieval deficits, but they are milder and rarer than the apraxia and impairments in executive functions. Visuospatial impairments have also been observed in CBD, as well as drawing deficits. 73% of CBD patients have depression, and apathy (40%), irritability (20%) and agitation (20%) also occur.

In PSP patients, verbal attention is often normal, but deficits in visual attention are common. Executive dysfunction occurs early in PSP and it stems from deficits of the basal ganglia and prefrontal cortex. People with CBD show compromised planning, cognitive flexibility and problem solving. The progression of these deficits is especially rapid in PSP patients, compared to the other patients. Speech problems also occur earlier and are more common in PSP than in other movement disorder groups. Verbal fluency is impaired and letter fluency is more affected than category fluency. There are episodic memory deficits present in PSP, but these are less severe than the deficits in PDD and DLB. Free recall is impaired, but recognition discrimination is relatively normal. Remote memory is not really affected. PSPS patients show oculomotor deficits; the voluntary vertical eye movements are deficit. They show a reduced blinking frequency. Apathy is the most common neuropsychiatric symptom in patients with PSP and the prevalence may be as high as 90%. It is far more common and severe in PSP than PD. People with PSP also show behavioural signs of disinhibition. They may also show a change in personality, including increased irritability.

Neuropsychological assessment

For the assessment of these movement disorders, medical records should be reviewed. This is especially the case for the disorders presenting with dementias. Next to the usual information gleaned from medical records, reviews for patients with movement disorders should also address other things. They should assess age and age at onset of movement disorder symptoms, the age at onset of cognitive changes, the side of onset of movement disorder symptoms (DBL and PSP are more symmetric, while PD and CBD are asymmetric), the nature of parkinsonian symptoms, presence of motor fluctuations, the existence of pathological daytime sleeping, presence of visual problems and tremors that might interfere with test administration, the presence of attention fluctuations and hallucinations, comorbid medical conditions, utilization of certain medications that might impact concentration or memory and history of prior neurosurgical intervention for movement disorder

Interview

The information that is obtained from medical record review, should be verified during interview. It should also be established whether there is a family history of dementias or movement disorders. During interviews, the question arises whether patients and care givers are accurate in reporting cognitive, behavioural and functional changes. Research has found that patients are accurate reporters of disability, even when there is cognitive compromise or depression. The discrepancies between patient reports and care partner reports increase as a function of patient cognitive impairment and depression. Patients frequently complain of memory disorders initially, but what they describe as memory disorders may actually represent other deficits. For example, the inability to recall how to operate equipment may refer to executive dysfunction. It is important to prepare the patient for evaluation during the interview. The interviewer needs to make the patient as less anxious as possible. Patients should be encouraged to report what they feel. Patients should also be monitored for fatigue and also whether they’re alert or not (especially patients with DLB).

Screening instruments

Neuropsychologists need to screen for cognitive impairment in persons with movement disorders. The use of screening instruments has been the subject of empirical investigation in PD and PDD, but has received less attention in PSP, CBD and DLB. It is important to know how well screening instruments perform in detecting cognitive impairments in movement disorders. The advantages of cognitive screening instruments include the simple administration and scoring, the brevity, patient acceptability and limited expense. Another issue is that there are few screening instruments that have been developed for movement disorders. Recently, more emphasis has been placed on developing instruments for the use of PD and PDD, but no instruments have been developed specifically for PSP, CBD and DLB. Two widely used screening instruments not specifically designed for PDD and DLB are the Mini-Mental State Exam (MMSE) and the Dementia Rating Scale (DRS). However, the MMSE de-emphasizes working memory and executive functions and lacks sensitivity to cognitive changes associated with subcortical-frontal dysfunction. The DRS’s sensitivity in detecting cognitive impairment in PD has not been adequately addressed. Some subtests of the DRS are more helpful in distinguishing PD patients from healthy controls than others.

Test selection should consider the patient’s condition or the differential diagnosis, the patient and caregiver concerns, the referral questions, the properties of the test and the patient’s ability to tolerate and cooperate with the test. When researchers evaluate patients with movement disorders, awareness of the impact of various features of movement disorders, like sleep disturbance, apraxia and motor fluctuations, on test performance need to be considered. Standard test administration methods may have to be modified when working with these patients. People with PSP have downward gaze palsy, and this makes it difficult for them to voluntarily look down at test forms. Patients with speech impairments may want to point rather than giving oral responses. Patients with tremors or apraxia may require help from the examiner when completing tests or questionnaires that require writing or circling alternatives. These scales might be administered verbally. It is also recommended to test patients when they are on antiparkinsonian medication. Another issue in PDD and PD is that symptoms of depression and anxiety may overlap with those of the movement disorder. Sleep disturbance, lack of energy, psychomotor retardation, sexual dysfunction and masked facial expressions can be observed in PDD, DLB, PSP and depression. Some scientists have suggested not to look at morning awakening and psychomotor slowing when diagnosing depression in PD. Rating scales might overestimate depression.

Access: 
Public
Caregiver Burden, a clinical review by Adelman, Tmanova, Delgado, Dion & Lachs - 2014 - Article

Caregiver Burden, a clinical review by Adelman, Tmanova, Delgado, Dion & Lachs - 2014 - Article

Worldwide, millions of individuals provide support to midlife and older adults, for example to their own husband or wife who is chronically ill. These caregivers are often affected by physical, mental and psychological health problems, such as late-life depression, geriatric suicide, social isolation and caregiver burden. The current paper focuses on the latter: caregiver burden. The paper is a review and 1) emphasizes the clinicians responsibility to recognize caregiver burden, 2) provides tools for assessing caregiver burden and 3 ) provides insight into interventions that prevent or mitigate caregiver burden.

What is caregiver burden?

In the International Classification of Diseases (ICD-10), there is no official definition or code for caregiver burden. A useful definition is given by Zarit and colleagues (1986): ‘The extent to which caregivers perceive that caregiving has had an adverse effect on their emotional, social, financial, physical and spiritual functioning’.
This definition emphasizes two important aspects of caregiver burden: 1) the multidimensional toll it exacts on caregivers 2) the highly individualized experience: what for one person may result in a caregiver burden, can be expressed much less stressful for another person.

What is the epidemiology of caregiving?

Around 90% of in-home long-term care for adults is provided by unpaid family or informal caregivers. Many of these family caregivers are untrained and often feel not well prepared to take on these (medically skilled) tasks. Most caregivers are female, and spend on average 20.5 hours per week providing care. In 2009, 43.5 million individuals in the United States provided care for an adult older than 50 years of age. Approximately 32% of caregivers reported high caregiver burden, and 19% reported medium caregiver burden.

What are risk factors for caregiver burden?

Risk factors for caregiver burden are: female, low education, living with the care recipient, depression, social isolation, financial stress, higher number of hours spent caregiving, and lack of choice in being a caregiver.

What did prior studies focus on?

Many studies focused on caregiver burden are limited by an emphasis on homogeneous diagnostic groups. For example, they focus only on caregivers who take care for patients with Alzheimer disease, cancer or a stroke. An advantage of this homogeneous approach is that it may provide insight in symptoms or the degree for that specific disease: some diseases may result in more caregiver burden than others. A disadvantage however is that it limits the generalizability and identification of features that are common across diagnoses.

How to improve diagnosis and assessment of caregiver burden?

According to the authors, physicians need to interact with family, and in particular with primary caregivers (the invisible patient). Little attention has been paid to how clinicians should relate to family caregivers. The following approach in recommended by The National Consensus Development Conference for Caregiver Assessments:

  1. Identify the primary and additional caregivers

  2. Incorporate the needs and preferences of both the care recipient and the caregiver in all care planning

  3. Improve caregivers’ understanding of their role and teach them the skills necessary to carry out the tasks of caregiving

  4. Recognize the need for longitudinal, periodic assessment of care outcomes for the care recipient and family caregiver

The present article provides topics and questions that a clinician can ask to assess caregivers (step 2). It also provides suggested openings to initiate conversions with a caregiver.

Which interventions for caregiver burden exist?

Finally, the present study reviewed several meta-analyses and reviews to provide insight into present interventions for caregiver burden. Several interventions are developed in different domains: for example psychosocial, psychoeducational and pharmalogical. Most interventions showed weak (0.2) or moderate effect sizes (Cohen’s d). Even with small or modest effect sizes, many interventions decreases symptoms of caregiver burden and are warranted.

Some practical interventions for clinicians to reduce caregiver burden are given:

  • Encourage the caregiver to function as a member of the care team: be transparent, proactively include the caregiver in the care team.

  • Encourage caregivers to improve self-care and to maintain their health (as often caregivers tend to neglect their own health).

  • Provide education and information: educate caregivers about the illness and specific needs of the care recipient. For example, teach them proper techniques for lifting and transferring the care recipient.

  • Use the support of technology, such as emergency response systems. For example, install an intercom system so that the care recipient can call for help when the caregiver is not at home.

  • Coordinate for Assistance with care. Many caregivers are not aware of assistive services, such as medical adult day programs, meal delivery services and volunteer programs. Coordinating such care may lower the experienced burden of caregivers.

  • Encourage caregivers to access respite care. For example, the care recipient can stay a brief period of time in an PACE program (Program of All-inclusive Care for the Elderly) to relieve the caregiver.

Access: 
Public
Decision-making in older people with dementia - Viloria Jiménez, Chung Jaén, Vigara García, & Barahona-Alvarez - 2013 - Article

Decision-making in older people with dementia - Viloria Jiménez, Chung Jaén, Vigara García, & Barahona-Alvarez - 2013 - Article

Introduction

Dementia is a syndrome defined by a progressive impairment in cognition, function and behaviour, with a considerable burden in terms of health and social care, and economic costs. As Alzheimer’s disease and other dementias advance, the patient’s capacity, competence and possibility of participation in decisionmaking decrease. Many ethical issues arise while assessing and treating patients with cognitive impairment. A series of ethical dilemmas will be explored in this article. Many of the areas of controversy and each requiring skill in communication in order to reach a consensus decision. This article reviews crucial points in decision-making for people with dementia and their families and caregivers.

Ethical principles and the decision-making process

For a medical practice to be considered ‘ethical’, it must include all four of the Beauchamp principles: autonomy, justice, beneficence and non-maleficence. Autonomy means that the patient must be capable of thought, intention and action when taking decisions with regard to health care procedures. Justice means that the treatments and resources must be distributed equally among all groups in society. Beneficence means that the patient’s right to receive treatment in accordance with their best interests should be defended. Non-maleficence means that possible damages should be prevented and avoided.

The decision-making process

Decision-making capacity is conceptualized as involving four decisional abilities. The first ability describes the understanding of relevant information (i.e. different options of treatments, risk and benefits). The second ability describes the appreciation of the information by applying it to one personal situation. The third ability describes the reasoning through the information in a rational manner. The fourth and last ability describes the communication of a clear and consistent choice. For patients with dementia, impaired decisional competence is a limiting factor for patients’ participation. Therefore, the decision-making process is a crucial issue during the progression of the disease, with different considerations and key points in mild, moderate, severe and terminal dementia.

Capacity

The patient’s capacity and will are important to the decision-making process relevant to a procedure or a treatment. In order to determine the patient’s capacity, it can be questioned whether the the patient can express his/her own personal preferences and whether the patient understands the benefits and risks. However, evaluating capacity for decision-making in a patient with dementia is a very subjective and inconsistent process. Patients with dementia are furthermore deprives in their driving capacity. Although a clinician may be able to predict a patient’s impaired driving ability, this is not sufficient to determine real driving competence in patients with mild dementia. Another form of capacity which is described is financial capacity. Financial capacity encompasses a wide range of judgement and conceptual abilities, ranging from basic skills like counting coins to more complex skills such as paying bills and exercising financial judgement. It is stated that clinicians can assess financial capacity in patients with cognitive impairment with a brief, semistructured clinical interview

Timely diagnosis of Alzheimer Disease and other dementias

Early diagnosis of dementia has both advantages and disadvantages. Advantages include encouragement of the initiation of strategies to delay dependence and institutionalization and early treatment to slow progression before impairment. For family members, early diagnosis can ensure appropriate family support during the progression of the disease, reduce stress and caregiver burden and provide answers and solutions for some questions concerning the cognitive and functional decline. Disadvantages include worries about the acceptance of the diagnosis at an early stage of the disease and risk of depression and suicide.
Because of both the advantages and disadvantages of an early diagnosis, some family members and caregivers show reluctance about patients being informed of the diagnosis of dementia. Although families members and clinicians often worry about which reaction the patient will give after the diagnosis has been confirmed, many studies show that disclosure of a dementia diagnosis seldom prompts a catastrophic emotional reaction. All clinicians and family members must respect the patient’s will to know or not to know and conspiracy of silence must be avoided.

Informed consent and advance directives

In a patient with dementia, the consent should be given by the patient themself  while still capable. Thus it is important to determine capacity before accepting a patient’s consent or refusal to a procedure or treatment. Ideally a patient’s preferences for treatments that prolong life should be established before the disease is advanced. Advance directives are designed to maintain autonomy and to determine the patient’s wishes about diagnostic tests and treatments if he or she is incapable of expressing them at a given time.

Treatment of dementia

There are no drug treatments available that can provide a cure for dementia. However, treatments have been invented that can improve cognitive symptoms, or temporarily slow down their progression. There are two main types of medication: acetylcholinesterase inhibitors (AChEI) and Nmethyl-D-aspartate (NMDA). However, when the patient reaches the terminal stage of disease, consideration should be given for stopping the drugs and palliative management should take precedent.

Palliative care and main issues in the end stages

In patients with any type of dementia there are many needs that involve palliative care, such as pain management, location of care and attention to caregiver burden. The general barriers against providing palliative care for patients with dementia have been shown to be economic and lack of information about needs of the patient. The key points in palliative care for dementia are symptom control, assessment of the need for rehabilitation, information about technical aids, co-ordinating care, spiritual and psychosocial support, and helping the families through all stages of the disease.

The main issues in the end stages of dementia are:

1. Behavioural symptoms. These symptoms vary significantly in form and intensity. Non-pharmacological measures (such as modifying the environment, avoiding physical restraints) should be used before medications.
2. Risk of delirium.
3. Eating disorders. Common problems are poor oral intake, difficulty swallowing, weight loss and malnutrition. Basic interventions to be considered include modifying the food texture, more frequent meals with smaller amounts and use of oral supplementation.
4. Pain. This symptom is frequently underestimated and that can be difficult to assess. The main causes of pain in people with dementia are immobility, pressure ulcers, and constipation.
5. Hospitalization and problems of communication. Some researchers state that if the patient seems to be experiencing more pleasure than suffering overall, it may be justified to continue with life-prolonging measures that can always be re-evaluated in case the situation changes.
6. End of life care. There is a need to anticipate what steps to take in the late stage of dementia, including where patients will spend their last days.

Bulletpoints

  • Dementia is a syndrome characterized by a progressive impairment in cognition, function and behaviour, with a considerable burden in terms of health and social care, and economic costs. As Alzheimer’s disease and other dementias advance, the patient’s capacity, competence and possibility of participation in decisionmaking decrease.
  • For a medical practice to be considered ‘ethical’, it must respect all four of the Beauchamp principles: autonomy, justice, beneficence and non-maleficence. 
  • For patients with dementia, impaired decisional competence is a limiting factor for patients’ participation. Therefore, the decision-making process is a crucial issue during the progression of the disease, with different considerations and key points in mild, moderate, severe and terminal dementia.
  • Early diagnosis of dementia has both advantages and disadvantages. 
  • Treatments have been developed that can improve cognitive symptoms, or temporarily slow down their progression. There are two main types of medication: acetylcholinesterase inhibitors (AChEI) and Nmethyl-D-aspartate (NMDA).
  • The key points in palliative care for dementia are symptom control, assessment of the need for rehabilitation, information about technical aids, co-ordinating care, spiritual and psychosocial support, and helping the families through all stages of the disease.

ExamTickets

  • Know how to describe which ethical issues arise while assessing and treating patients with cognitive impairment.
  • Know how to explain the four decisional abilities which are part of decision-making capacity.
  • Know which questions may be asked in order to determine a patient’s capacity.
Access: 
Public
Driving evaluation in Older Adults - Manning & Schultheis - 2013 - Article

Driving evaluation in Older Adults - Manning & Schultheis - 2013 - Article

In our society, there is a big emphasis on autonomy and mobility. It is therefore not so surprising that our society is dependent on automobiles and recent studies have shown that individuals maintain active driver status and stay on the road later into life. There are more drivers over the age of 65 than ever before, and this number will probably keep growing. A high age and age-related cognitive conditions negatively affect the visual, cognitive and physical abilities that are necessary for safe driving. Clinicians are often called upon to comment on an older patient’s ability to remain active drivers. Ceasing driving can have negative ramifications on everyday activities, like social activities and getting to work. It also has a negative effect on the sense of autonomy and it’s also associated with poo health and depression. It’s difficult to evaluate the safety of the older driver in society, while trying to balance the person’s need for mobility and quality of life.

Driving research

According to research, the relationship between driving performance and driving outcome can be conceptualized as a triangle or iceberg. At the top of the iceberg are driving errors that produce accidents, like running a red light. The bigger middle part consists of less obvious driving errors. These driving errors can increase crash risk or result in near crashes. The bottom of the triangle or iceberg is the optimal driving section. There are two main areas of driving research that have evolved in investigating driving errors. The first tries to figure out the relationship between specific driving errors of different severities and crash involvement. The second tries to understand driver characteristics that are related to a high likelihood of committing driving errors. For clinicians who deal with older people, it is important to understand how age and cognition contribute to these driving errors.

In driving research, it is important to look at the variability in how driving outcome or driving performance is defined in the laboratory. This behaviour is often not defined in the same way. Most studies define driving performance in the following way: behind the wheel examination, performing on driving simulators, performance on instrumented vehicles, self-reported driving behaviours, documented crash involvement or crash statistics. There are significant differences across these methods. The behind-the-wheel examination is the most clinically useful method of evaluating driving performance. It is an on-road evaluation conducted by a driving specialist in a dual-controlled vehicle. Together with the driving specialist’s off-road clinical evaluation, it compromises a clinical driving evaluation. Behind-the-wheel examinations vary, because there are no mandatory rules or guidelines. In most of the cases, the person being evaluated is guided through identified routes and his/her driving behaviours are observed. There are two types of studies done in driving research. The first type are the studies conducted with a clinical focus and the second are studies conducted with a transportation research focus. These two areas should inform each other, but they often don’t. most of the research is done by transportation researchers and it is typically not published in journals that are accessed by clinicians.

Characteristics of health older drivers

There is a misconception about older drivers and the misconception is that older drivers are more often involved in automobile crashes compared to other age groups. However, empirical data does not support this claim. Some studies even show that older drivers have lower crash rates than all other age groups. What research did find, is that crash risk increases as driving exposure (annual miles driven) decreases. Older people who drive less than 2000 miles annually, which is approximately 13% of the older drivers, have one of the largest crash rates. Older adults are also more likely to be involved in certain types of crashes compared to younger and middle-aged drivers. Studies show that drivers aged 65+ are more likely to be involved in crashes at stop signs, intersections, changing lanes and while turning.

Driving errors

Studies have shown that high crash rates at intersections controlled by a stop sign were noted in older drivers (age 65-80) and younger drivers (18-21) who were more likely to run stop signs, compared to middle aged drivers. Older drivers seem to show a dangerous braking profile compared to middle age adults. The older adults brake suddenly. They begin breaking closer to the stop sign and progress faster from the initial brake press to maximum breaking. This results in a short stop. Errors in judgment and/or attention are also related to increased crash risk in older drivers while changing lanes. According to studies, crashes that occurred when the driver field to yield the right of way increased with age and they occurred more often when the driving was turning left. Many old drivers fail to evaluate the correct speed of the oncoming vehicle. The oldest drivers fail to see some vehicles.

Studies show that different cognitive abilities are associated with different driving performance measures in healthy older people, who do not have a cognitive impairment. Research has shown that older adults make certain errors more often than other drivers, such as speed control, lane changes, parallel parking and starting the car and pulling away from the curb. Older adults also committed more high crash-risk driving errors than middle-aged drivers. Older drivers often fail to check for traffic before changing lanes. Older adults are also more susceptible to distraction. Many studies have also shown that when the executive functions of the older adults are intact, they are less likely to make driving errors.

Driving in older adults with neurological diseases

Early work suggested that older people with Alzheimer’s Disease had an increased risk of crashes compared to age-matched controls, but recent studies have found no relationship between dementia and crash risk. Crash rates may not differ between health older people and people with Alzheimer’s Disease, but these two groups differ on driving errors committed. One studied showed that people with Alzheimer’s Disease only made more errors in lane changes. One big study that tested drivers with the behind-the-wheel examination, showed that increased age, greater severity of dementia and lower education were associated with higher rates of behind-the-wheel failure. Only 22% of people with Alzheimer’s Disease failed the exam. So, despite the evidence that older drivers as a group commit more high crash-risk driving errors than health people do, many older drivers with Alzheimer’s Disease are able to maintain safe routine driving over several years. However, the ability of drivers with Alzheimer’s Disease to adapt to novel driving situations is compromised compared to older adults without this neurocognitive condition. Other studies have found that cognitive performance, working memory and verbal fluency are related to crashes. People with Alzheimer’s Disease were also found to be more likely to engage in sudden vehicle slowing, which increases the risk of being struck from behind. Sudden slowing was associated with multiple cognitive abilities, but executive functioning was associated with the greatest increase in risk of unsafe behaviour.

Drivers with Parkinson’s Disease

Evidence suggests that older adults with Parkinson’s Disease are more likely to commit certain driving errors than healthy older adults. These errors involve lane changes, backing out of space, not checking the blind spot, indecisiveness at intersections and reduced use of rear- and side-view windows. Drivers with Parkinson’s Disease committed more errors than healthy people when turning, maintaining lanes or at stop signs. They also committed more safety errors according to a big study, but they did not commit more high-crash risk errors. Most people with Parkinson’s Disease are able to pass clinical driving evaluations. The drivers with Parkinson’s Disease do not limit their driving and they make as many miles a week and drive as many times as healthy adults do. When looking at cognitive measures, the drivers with Parkinson’s Disease who are seen as safe, do not differ cognitively from healthy drivers. Drivers with Parkinson’s Disease who were seen as marginally safe, performed worse on measures of verbal learning and memory, working memory, finger tapping and visuospatial ability than healthy drivers did. These results show that working memory and visuospatial abilities are important for safe driving. Studies have also shown that disease duration and severity have a negative impact on driving performance (longer duration and severity, more errors). Also, contrast sensitivity (the ability to see objects that do not stand out from the background) has a negative effect on driving safely (lower sensitivity, more errors).

Older drivers with mild cognitive impairment

There is not so much research on the driving performance of older people with mild cognitive impairment as is on drivers with Alzheimer’s Disease and Parkinson’s Disease. One looked at older drivers with mild cognitive impairment and five error types: steering steadiness, turning, gap judgment, lane control and maintaining proper speed. There was also a control group of healthy adults. The results showed that the overall mean errors did not differ between adults with mild cognitive impairment and cognitive healthy older people. The drivers were also judged by a driving specialist and when the groups were compared on the ratings of this specialist, a higher proportion of adults with mild cognitive impairment were judged as showing not optimal performance on left turns, overall driving performance and lane control. The driving performance of people with mild cognitive impairment was less than optimal, but these individuals are not impaired. There were no drivers who were seen as unsafe drivers. The researchers of this study suggest that drivers with mild cognitive impairment don’t perform optimal, because their executive functions are slightly impaired.

Application to clinical neuropsychology

Clinical neuropsychologists are often asked to comment on the driving abilities of older adults. It is quite a responsibility to decide whether somebody is able to drive or has to stop driving. It is difficult for clinicians to translate the statistically significant relationships between cognition and driving into clinically meaningful outcomes for older people. There are no guidelines as to what constitutes a sufficient assessment battery for determining driving fitness. Researchers urge clinicians to consider risk factors for decreased driving ability and to use informant report as an important method in determining the risk of the older patient with dementia. The writers think that neuropsychological assessment can make a great contribution to clinical driving evaluations. Also, if it’s possible, a cognitive assessment should be included in the driver evaluation process. The clinical driving evaluation is the gold standard for driving assessment. Driving simulation is of great use, but it’s not really a good clinical tool. It is important to remember that what constitutes a sufficient clinical neuropsychological evaluation may not constitute adequate neuropsychological assessment in driving ability. Research needs to provide direction for the selection of neuropsychological measures that need to be administered. Some domains associated with driving performance have been identified in the literature and some of these are attention, reaction time, judgment, inhibition, working memory and spatial perception.

Access: 
Public
Clinical Utility of Office-Based Cognitive Predictors of Fitness to Drive in Persons with Dementia: A Systematic Review - Molnar, Patel, Marshall, Man-Son-Hing & Wilson - 2006 - Article

Clinical Utility of Office-Based Cognitive Predictors of Fitness to Drive in Persons with Dementia: A Systematic Review - Molnar, Patel, Marshall, Man-Son-Hing & Wilson - 2006 - Article

The population of developed countries continues to age, so the prevalence of age-associated disease will increase. This also means that the number of persons with dementia who are actively driving is expected to increase. Since the late 1960s, the matter of driving in people with dementia has become a topic of growing societal concern. While there are some studies that state that there are no increased risk of motor vehicle crashes (MVC) in people with dementia, most studies show that, as a group, people with dementia have a 2.5 to 4.7 times greater risk of MVC than control groups. There might not be a single precise and generalized risk estimate achievable, because the estimates will vary because of different sample sizes, different clinical populations, varying levels of driving exposure, different definitions of MVC, different means of measuring MVC rate and whether the MVC rate is calculated per distance driven or per driver. However, the fundamental finding of many studies is that people with dementia are at a higher risk of experiencing a MVC than the population average. Therefore, early driving researchers recommended that all patients diagnosed with dementia cease driving. Arguments that justify this position are the variability within the category of mild dementia, the unpredictability of progression rates, the different effects on various types of dementia on fitness to drive and the increased propensity of people with dementia to experience sudden acute confusional states. Basically, the arguments regarding dementia and driving focus on the unpredictability of progression to unsafe states.

Some people have argued that the conservative approach of removing the licences of all people diagnosed with dementia, presents several problems while not resolving the safety concern. This approach penalizes patients who have been given a diagnosis of dementia and this may discourage people with possible dementia from seeking a diagnosis. Also, some people have reversible disorders and there are sometimes uncertainties with diagnoses, so the licence might be removed from people who have reversible disorders rather than progressive dementia. Some studies have shown that many people with dementia may still be safe to drive. One study showed that the majority of people with dementia who were actively driving had not been involved in MVCs. However, certain biases (recall bias) might limit this study. It is often hard to assess driving exposure and that limits database research. There are some medical associations that recognize that some people with mild dementia may be safe to continue driving. They do not recommend reporting based on diagnosis, but on individual functional assessment of persons with mild dementia. There are guidelines that provide recommendations for a functional assessment of fitness to drive, like the American Medical Association’s (AMA) document called ‘Physician’s Guide to Assessing and Counseling Older Drivers.’ This guide assists clinicians by providing tools to screen all drivers rather than focusing on the evaluation of dementia exclusively. All screening tests must be as rigorously evaluated and validated as more-complex assessment procedures.

For more evidence-based guidelines for clinicians, a systematic review of the literature, from a clinical perspective, is required. In this article, the evidence for future versions of guidelines will be examined via a systematic literature review of studies that have attempted to answer the questions: ‘Which office-based cognitive tests have been analysed in a manner that permits their immediate application in frontline clinical settings in the assessment of fitness to drive in persons with dementia?’ this review also looks whether tests are associated with MVCs, whether evidence-based and validated cu-toff scores are provided and whether the standard psychometric properties of the cut-off scores are reported. Because there is much variability in study designs, definitions of MVC and outcome measures, a meta-analysis is not possible.

Method

The focus of the review is on in-office assessment and tests that require specialized equipment not readily available in usual healthcare settings were not included. When it was not certain if equipment was required, the test was included in the review. Supplementary skills that are related to driving, like strategic and operational abilities were not examined. Complementary areas, like sensory functions, sociodemographic factors and behavioural factors were not examined. Because of ethical considerations, randomized trials can’t be employed. To collect cognitive tests, all cohort, correlation and case-control studies that tried to answer the main question posed were included. Only studies that used accepted diagnostic criteria for dementia (from the DSM), or Alzheimer’s disease criteria from the National Institute of Neurological and Communicative Disorders and Stroke- Alzheimer’s Disease and Related Disorders Association (NINCDS-ADRDA) were selected. Also, only articles published in English were considered. The literature was searched in a couple of databases. First, the researchers looked at the title and selected articles were looked at more closely to see whether they would fit in the review. The texts of 164 articles were reviewed, with 16 articles meeting the inclusion criteria. The primary outcome was history of crash for six studies, stimulator test results for four studies and on-road assessment for six studies. A great amount of inconsistency regarding the association between test results and driving outcome measures was found. The outcome measure used appeared to have an influence on findings. Positive associations of certain cognitive deficits were with the ability to drive as determined by performance-based testing protocols rather than with real-life performance.

Results

The association between each test and MVC and the findings within each domain show a great amount of variability. These are probably the result of a number of methodological factors, like different sample sizes, multiple predictor variables, different outcome measures employed and performance measures. The outcome measures have limitations and these also contribute to the variable results. In table 4 on page 1819 of the original article, you can read all the limitations of every construct studied. This study shows a significant research gap that represents a barrier to the creation of evidence-based fitness-to-drive guidelines. The results with respect to the association between individual tests and MVCs were variable, but the consistent findings of these studies was that none of the included studies were analysed in a manner that could generate clinically usable tools for front-line clinicians. The studies also don’t give data required for the development of evidence-based fitness to drive guidelines. Clinicians need to label a patients as a safe or unsafe driver. This task requires that tests have evidence-based cut-off scores that suggest a course of action. However, all the studies (except for one) reviewed didn’t look at cut-off scores, but at association. Knowing that a certain cognitive test is associated with risk of MVC is helpful in selecting tests that merit further study. However, when there are no cut-off scores, the association is of little practical utility. The study that did provide cut-off scores did not provide psychometric properties, like sensitivity or specificity. It is difficult to find cut-off scores. The cognitive scores of people who are fit to drive and those who are unfit to drive probably have overlapping distributions. Because of the overlapping test scores of safe and unsafe drivers, it is unlikely that a single clinically usable cut-off score will be found for most tests. This may be the reason why some studies do not report cut-off scores.

Multivariate analytic techniques are the conventional analytic approaches employed in the field of research. These techniques are based on the assumption that all needed information is available at one point in time. This assumption may be valid in subspecialty settings, but the techniques do not model routine front-line clinical decision-making. Multivariate equations are never employed in front-line clinical practice. In clinical practice, decisions are first made based on minimal information. Other tests are applied to patients whose status could not be determined via the initial information. This is a more efficient approach to maximize ability to diagnose while minimizing cost and morbidity associated with more-expensive and invasive tests. If driving researchers do develop tools to assist front-line clinicians, then they should also look beyond the conventional multivariate techniques to include cut-off based approaches that better model front-line clinical decision-making. So, research needs to move on finding out more about cut-off scores and deciding what values to aim for with cut-off scores. There is also not much research on the determination of risk threshold. How much risk is too much risk? Without a risk threshold, clinicians will have to base their decisions of safe or unsafe drivers on their personal opinion. A risk threshold is needed to standardize the practice. Standardized risk thresholds will set the criteria that cut-off scores are to meet and researchers can compare different studies more easily in that way. Another thing that future research can examine, is the pattern of cognitive deficits and specific types of deficits on cognitive tests and how they relate to the fitness to drive. Researchers should also be encourage to perform systematic reviews of cognitive impairment and driving. Future research should also have adequate sample size to avoid error.

Access: 
Public
Interventions to reduce the adverse psychosocial impact of driving cessation on older adults - Windsor & Anstey - 2006 - Article

Interventions to reduce the adverse psychosocial impact of driving cessation on older adults - Windsor & Anstey - 2006 - Article

Changes in the ageing of populations means that more and more drivers will have to face with the fact that they might have to give up driving due to health or functional limitations. Many studies in different countries have shown that many people after the age of 80-85 should rely on alternative modes of transport. Studies have shown that there are negative social and psychological consequences of driving cessation. For many older people, the feeling of being able to drive to being an ex-driver goes together with a sense of lost independence, depression and social isolation. Mental health and social integration is important for the general wellbeing and it is also important for the prevention of dementia and other health problems when people age. It is therefore important to have interventions that address the negative consequences of driving cessation. There have only been a couple of interventions that target older drivers and most of these programs aim to promote safety. This article is a review in which two areas of research are surveyed. Some studies that are reviewed are about the implications for intervention programs designed to promote safety for older adults. Other studies that are studied are studies about reducing the negative consequences of driving cessation, when safe driving is not an option anymore.

Interventions for driving safely for longer

Although we know that there are issues associated with older driver safety, there have only been a couple of studies conducted to evaluate the effectiveness of existing intervention programs. These studies describe approaches to interventions that fall into two categories. The first one is the cognitive speed-of-processing intervention. These are designed to improve aspects of visual processing and attention. The second category is the educational intervention. This is designed to promote effective self-regulation and good adaptation of driving behaviour.

Cognitive interventions

Studies have shown that cognitive abilities are important factors when it comes to safe driving. Visual-processing speed and visual selective attention are important aspects of cognition for driving. These things have been assessed among older drivers by using the so-called ‘useful field of view test,’ UFOV. The UFOV looks at to which extent older adults are capable of extracting visual information without movement of they head or eyes. The testing process sometimes requires localization, detection or identification of certain targets. Studies have showed that older drivers with UFOV impairments have more at-fault crashes and driver simulator crashes. These studies have also shown that with the appropriate training (speed-of-processing training) performance on the UFOV can improve. This suggests that the driving capacity of older adults could be improved, or maintained at acceptable levels. Of course, this could only be done through interventions that give speed of processing training.

Some studies have looked at the impact of speed-of-processing training on driving outcomes. One study looked at individuals with high-risk scores according to the UFOV. Some of these people received speed-of-processing training and others received traditional driver training. There was also a low-risk control group. The results showed that the group that received speed-of-processing training improved on the UFOV task to a level that looked like the level of the low-risk group. The group that underwent traditional driver training did not show an improvement in UFOV performance. Speed-of-processing training also had a beneficial effect on driving performance. Other studies have also shown that the UFOV might be of particular use for improving the driving outcomes of people who have an impaired speed of visual processing. The ACTIVE trial is a large-scale randomized controlled trial of cognitive training interventions with older adults. It has looked at the effects of speed of processing training on cognitive tests and functional activities. This trial has also shown that speed of processing training had a positive effect on the cognitive measures of an old person. So it seems that studies have found results that have positive implications for clinical interventions for older drivers’ cognitive capacity. With these interventions, they can drive more safely and longer. But, more research is needed to determine whether there is a certain age at which those interventions are most beneficial. Research should also look at whether benefits of training in preventing decline are ‘better’ than benefits for improving performance. Studies must also examine what the most effective mode is of delivering the cognitive training. It could be the case that there are other techniques that can enhance the driving ability, and not just the ones based on UFOV.

Educational interventions

There are a couple of studies that have looked at the education-based driving interventions and outcomes. One such study gave older drivers a driving decision workbook. This is a self-assessment tool which asks older drivers to identify potential problems faced in the domains of driving attitudes, driving ability, health and behaviour. This book also provided the older adults with feedback as to how certain problems might be addressed. The results of the study showed that the people who completed the workbook indicated that the exercise increased their awareness of age-related changes that could affect driving and they also indicated that is served as a reminder of issues that relate to road-safety. This study was limited because of the sample and a lack of follow-up data, but it does show that using a workbook has promise. Another study shows that older drivers have the ability to improve on a driving task that they had familiarity with. Both the group that received educational training about the driving environment and driving performance as well as the control group that just underwent the on-road testing without the educational intervention improved.

The most comprehensive designed educational program for older drivers is the Knowledge Enhances Your Safety (KEYS) project. This intervention was developed to improve the safety of older drivers who have visual impairments. These older individuals are at high risk of accident involvement. The project used the social-cognitive theory and models that emphasize motivation, knowledge and self-efficacy for adaptive behaviour change. The older adults received a one-on-one session with a health educator. The educator told them about the implications of visual impairment for driving, strategies for avoiding hazards and he/she thought them more about the development of skills and build their confidence up. The project was evaluated and it revealed that drivers who had received the KEYS showed a greater awareness of their visual limitations and they also reported a higher degree of self-regulation of driving behaviour. However, another study that evaluated the KEYS found that older drivers that received educational training from KEYS did not show less crashes than the control group. This suggests that educational interventions may have only limited value in promoting older driver safety.

Other studies also looked at a model which saw vision and physical functioning as important for improving the capacity of driving safely. This model saw cognition as playing a crucial role in enabling driving capacity and effective self-monitoring. Many interventions also try to improve the cognitive abilities of older people. These interventions often use speed-of-processing training (UFOV) to enhance basic driving skills. Educational interventions try to promote better understanding of issues and difficulties associated with driving. Some studies suggest that educational interventions for older people benefit the people by facilitating the discussion of issues related to driving cessation with family members. This suggests that education programs might be more effectively targeted at helping older drivers to prepare for life after not driving anymore and not enhancing safety.

Clinical interventions for driving cessation

The most effective methods for reducing negative consequences of driving cessation are applied to the population level. These include improvements to existing transport services, to make them more accessible for older adults. Also, there are community-owned transport services that provide for the needs of older adults who don’t drive anymore. There are different interventions to address adverse psychological consequences of driving cessation. Social cognitive theory seems to offer a promising theoretical framework for interventions. People see giving up driving often as lost independence. The social cognitive theory focuses on self-efficacy, control over the environment and self-regulation and it helps older adults to re-evaluate what remains achievable in terms of mobility after driving cessation and to get a sense of control over the environment. Ceased drivers often face depression which results from reduced mobility, social isolation or threats to self-concept. This might also be lessened by interventions informed by social cognitive theory. Especially the promotion of self-efficacy has been identified as an important element for success in interventions to reduce depressive symptoms in older adults. So, social cognitive theory addresses threats to the self and independent mobility by promoting efficacy and knowledge about availability of alternative transportation.

It is important to have interventions informed by appropriate theory, but practical considerations are also important in the creation of approaches that address negative outcomes associated with driving cessation. One important approach that fits with the social cognitive theory framework is the active planning for driving cessation while people remain capable of driving. Strategies that can be used to plan for life after driving might include familiarization with transport alternatives, like public transport. They also include considering housing relocation when transport alternatives are not available and also initiating conversations of transport arrangements with family and friends. These activities provide benefits and also reinforce efficacy beliefs and allow older adults to adapt emotionally better to cessation. When you expect a negative event as part of a normal transitional process, you will more likely better adjust to it than experiencing a sudden loss. There are some interventions that have used educational approaches that help assist older adults to plan for driving cessation. Residents of the Australian Capital Territory (ACT) are given an educational booklet that addresses safe driving practices and techniques for self-evaluation when they turn 70. When these people 75, they receive another booklet that provides strategies in planning for driving cessation.

Future studies

Interventions that directly address problems like social isolation and reduced mobility are needed to help individuals who have already ceased driving and are experiencing a reduction in quality of life because of it. Problem-solving treatment is in line with the principles of social cognitive theory and could address the mobility, psychosocial and emotional difficulties. Psychosocial symptoms are a result of everyday problems and problem-solving treatment therefore equips people to better deal with current difficulties. This is done by outlining a problem-solving framework within the person identifies the problems, identifies achievable solutions and also identifies the mechanisms for attaining those solutions. This framework emphasises on people using their own skills and resources to solve problems and it will therefore enhance efficacy. This approach can also be administered by health professionals who did not have had psychotherapy training. This approach has also been found to be effective in improving depression outcomes for older adults. Interventions that try to reduce the negative consequences of driving cessation will probably also benefit from the involvement of supportive family and friends of the older person. Former drivers often rely on family and friends for the maintenance of mobility. This reliance can be associated with feelings of lost independence and because of this people may be reluctant to ask for help with non-essential trips. The educational intervention could stimulate discussion and family counselling could also provide an effective approach. This is probably best initiated while the older person is still driving.

Interventions for former drivers should be flexible, because they should be tailored to the specific needs of the older adult. Interventions should take into account where somebody lives (urban, regional or isolated areas) , the availability of public transport, the availability of residents willing to provide transport and the subjective experience of driving cessation. Interventions should also be different for older people who are still driving and older people who aren’t driving anymore. Someone who just stopped driving might be feeling distressed because of a loss of independence, while somebody who hasn’t been driving for a couple of years could be depressed because of social isolation. These people should receive different intervention programs. In the United States, a project was formed from a range of backgrounds like medical practice, seniors advocacy groups and traffic safety administrations. This project is called the Older Drivers Project and it’s goal is developing an improved approach to manage issues related to older drivers at a policy level. This project promotes the safety of road users and helps older adults to drive safely for as long as possible. This projects want to optimize the health status of drivers and it wants to create a safer driving environment through improvements to roads and traffic control devices. This project and other interventions should be explored really well, because the negative consequences of driving cessation for older adults are inevitable for a proportion of older road users.

Access: 
Public
Caregiver burden among dementia patient caregivers: A review of the literature - Etters Goodall & Harrison (2008) - Article

Caregiver burden among dementia patient caregivers: A review of the literature - Etters Goodall & Harrison (2008) - Article

Many studies have shown that family members who take care of relatives with dementia at home see the experience as stressful and frustrating. There is also a term for this and that term is caregiver burden (CB). Research has shown that more than 80% of Alzheimer’s disease caregivers have indicated that they frequently experience high levels of stress and about 50% of caregivers has said that they suffer from depression. Studies have shown that caregiver burden is associated with poor outcomes for caregivers, like decreased quality of life and depression. Caregiver burden is also associated with poor outcomes for dementia patients, like poor quality of life and early nursing home placement. Researchers have also agreed on a definition of caregiver burden and they decided that the term refers to a multidimensional response to psychological, emotional, social, physical and financial stressors that are associated with the caregiving experience. This term is different than the term ‘caregiving’, which only refers to the activities involved in providing help to relatives who can’t provide for themselves. This does not include the psychological distress that may come from it. Caregiver burden comes from the caregiver’s perception of activities and stressors and it is influenced by different psychosocial factors, like kinship, culture and the social environment.

The problem

It seems that caregiving for people with dementia is a global issue, because there’s a worldwide demographic shift to an aging population. People over the world have dementia. The caregiving responsibility will largely fall on family caregivers, like husbands and wives, but other family members are also seen more and more in these roles (like children). In the United States, 80% of the in-home care needed by persons with dementia is given by family members. When the severity of dementia increases, the amount of time needed to take care of the person also increases. So it is quite essential to identify and reduce important healthcare issues. A link has been found between earlier nursing home placement for people with dementia and caregiver burden. Caregivers who sought nursing home placement for the patient had higher burden scores, decreased social support and more family dysfunction than caregivers who did not seek nursing home placement. There are also other characteristics associated with nursing home placement and these are female, not living in the same household and no religious practice. Research has also found that adult children caregivers initiate early nursing home practice compared to spouse caregivers.

Caregiver characteristics

Many studies have examined caregiver characteristics that influence caregiver burden. One study found that wives experienced higher levels of caregiver burden compared to other relatives. This has been supported, but there were also studies that have found that daughters were overrepresented in the high caregiver burden group. A recent study has found that there are no significant differences in caregiver burden between adult children and spouses. It seems that closer kinship ties are associated with increased caregiver burden. Research has also shown that gender is an influence on kinship roles and perceptions of caregiver burden. Researchers have found that women report more health problems and depressive symptoms than male caregivers. However, there is also a study that did not find a difference between gender and measures of caregiver burden. One study did find that there are differences in the experience of caregiver burden. Male caregivers tend to experience a lack of positive outlooks and a lack of social support and female caregivers tend to experience an increase in the caregiver burden in their relationships with other relatives and also an increase in their own health problems. Other studies have found that coping strategies influence caregivers’ perceptions of caregiver burden. People with an emotion-focused coping strategy deal with feelings associated with the strain and people with problem-focused coping strategies try to confront the reality of the strain by dealing with the tangible consequences. It has been found that women reported more emotion-focused coping and men more problem-focused or mixed coping strategies to be effective.

It has also been found that self-efficacy behaviours may influence coping strategies when it comes to caregiver burden. Studies have found that caregivers who reported a stronger self-efficacy and who took time for themselves had a decreased burden and a greater quality of life. Culture also has an influence on this subject. This is because cultures shape a person’s perception of familial responsibilities and therefore also influence caregiver burden. Caregiver distress may be expressed differently among people from different cultures. Studies have found that Caucasian caregivers reported greater depression and saw caregiving as more stressful than African American caregivers. According to those studies, African American caregivers experienced almost the same amount of caregiver burden but they express it differently than Caucasian caregivers. In most Asian cultures, people have a greater sense of responsibility to care for elderly relatives and they also have a reluctance to discuss family problems. This leads to less social and emotional support for the caregivers and research has found that dementia caregivers from Korea and China scored higher on depression and burden than caregivers in the Western world.

Patient characteristics

Research has shown that the behavioural disturbances of dementia patients are one of the biggest factors contributing to caregiver burden. There is a strong association between behaviours of aggression, night-time wandering and agitation with caregiver burden and symptoms of depression. Behaviours that create more physical stress on caregivers (incontinence, immobility and difficulty walking) were predictors of nursing home placement. Other studies have shown that caregivers of mobile demented patients reported higher amounts of caregiver burden because of behavioural disturbances than non-mobile patients. It seems that behavioural disturbances influence caregiver burden and it is therefore important to recognize these problems so that they can be assessed and addressed. Studies did not find a relationship between caregiver burden and the dementia patient’s cognitive abilities. Caregiver burden is also influenced by patients’ type of dementia. Appraisals of caregiver burden were different between caregivers of persons with Alzheimer’s disease compared with frontotemporal dementia. It seems that caregivers of individuals with Alzheimer’s disease experience more disruption in their personal life than frontotemporal dementia caregivers and this last group is less satisfied with themselves as caregivers than the first group.

Conflict

Studies have also shown that caregiving for a demented relative is associated with family conflict, limitations in social life and a decrease in social support. Family conflicts can arise because of various things. One of the reasons is the caregiving situation itself and another reason is the old unresolved family issues that spill over in the caregiver’s experience. This may result in inference with support people might otherwise receive. Research has found that caregivers need help, appreciation and encouragements for their caregiving in order to lessen the degree of caregiver burden. Conflict in the family is associated with caregiver depression. Also, as cognitive impairment increases, caregivers view the family as more conflictual and less adaptable. Caregivers with prior good family functioning have less burden than caregivers with poor family functioning.

Assessment and interventions

Assessment of the degree of burden is important. There are different tools that assess the degree of burden. Some of these are the Zarit Burden Interview, the Screen for Caregiver Burden and the Caregiver Strain Index. These are all questionnaires. Assessment is not the only thing, it is also important to reduce caregiver burden. This is important for the dementia patients as well as the caregiver. When a caregiver receives emotional support and support in their physical health and can deal with the care of their relative with dementia, nursing home placement can be delayed. This will reduce the costs of long-term care significantly. Studies have shown that caregivers who changed certain things in their environments, like installing assistive devices in the bathroom, were less likely to institutionalize their family members with dementia. So it’s a good idea to educate caregivers on environmental changes. Older studies looked at single interventions and their effectiveness on reducing caregiver burden. One study found that a role-training intervention that focuses on helping the caregiver assimilate a more clinical belief set about their work as caregiver, resulted in less reported depression and burden. Programs that focused on family intervention by giving stress management, coping skills and education also reduced stress and depression among caregivers. These programs also reduce behaviour problems. Recent studies have found that multiple component interventions have better outcomes than single interventions.

Caregivers are different people and they all have different needs. We can’t assume that the same interventions will work among caregivers of various cultures. Research has shown that certain subgroups of caregivers responded less favourably to interventions than others. For example, in one study it was found that caregivers with a high school education or less responded more favourable to interventions than those with higher education. One study paired up dementia patients’ primary caregivers with nurse practitioners and the results showed that the patients showed an improvement in their behavioural and psychological symptoms and that the caregiver had less stress than the control group. It seems that various interventions have a positive immediate effect on caregivers’ burden. The broadest effects that have been found were from psychoeducational interventions that included the provision of information about caregiver issues and dementia. But, these interventions did not decrease the risk for institutionalization. Multi-component interventions (like education and support) were related to delayed institutionalization.

Nurse practitioners should address caregiver burden through prevention and early detection. Caregivers should be screened every six months and this helps to identify the caregivers who are at increased risk. When caregiver burden is identified, caregivers need to take part in active interventions. Good interventions give information about dementia, assist the family, get family members involved and gives information about safety issues. As dementia progresses, caregivers need more skill-based training to support the dementia patients. Of course, lessening the caregiver burden and delaying institutionalization in that way reduces the costs of long-term care.

Access: 
Public
Differential diagnosis of Alzheimer’s dementia and vascular dementia - Nelson - 2007 - Article

Differential diagnosis of Alzheimer’s dementia and vascular dementia - Nelson - 2007 - Article

Two types of dementia

Dementia is a disease which causes cognitive impairment. There are two typical types of dementia: Alzheimer’s dementia (AD) and vascular dementia (VD). AD is associated with cortical atrophy, and is called a cortical dementia. Memory impairments arise because of degeneration of mesial temporal structures, particularly entorhinal cortex and hippocampus.

Risk factors

Widespread, cortical neurotic plaques and neurofibrillary tangles are other important characters. Risk factors are being a woman, advanced age (60>), Down’s Syndrome, hypertension, and the presence of apolipoprotein E e 4.

Vascular dementia can result from an ischemic stroke, hemorrhagic stroke, and Binswanger’s Disease. Attenuation of periventricular white matter (leukoaraiosis), often observed in VD, is able to cause cognitive dysfunction. Risk factors are advanced age, history of hypertension, heart disease, hypercholesterimia, smoking, being a man and diabetes mellitus.

Diagnostic tools

DSM-IV is the most frequently used diagnostic tool for VD and AD. Also differentiations between subcortical/cortical and degenerative/non degenerative can be made. A problem with this is that a definitive diagnose of AD can only be established post-mortem. Another problem is the heterogeneous character of VD. To be diagnosed with VD or AD, according to DSM-IV, memory impairment plus another form of cognitive impairment and social or occupational impairment (compared to former functioning) should be found, but a delirium must be ruled out. To diagnose AD conditions of the central nervous system (Parkinson/Huntington/cerebrovascular disease), systemic conditions, substance-induced conditions and other Axis I disorders (for example major depression) should be ruled out.

Diagnostic challenges

Evidence of cognitive impairment is an important diagnostic feature, so standardized cognitive measures are needed. But there is no consensus found yet about this because of variability of participant inclusion criteria. Despite this there are two general findings: AD patients show more long-term memory impairment and VD patients show greater executive functioning impairments. Consino et al. found also that AD patients had significantly less leukoaraiosis and VD patients significantly more histories of hypertension and heart disease.

Because of these findings a new diagnosing system is proposed, based on neuropsychological test findings, neuroradiological findings, and vascular risk factors. It is very important that convergent date should be used to diagnose AD or VD. Cognitive profiles, medical information and neuroradiological information should all be used for discrimination between these two forms of dementia.

Access: 
Public
Assessment of decision-making capacity in older adults: an emerging area of practice and research - Moye & Marson (2007) - Article

Assessment of decision-making capacity in older adults: an emerging area of practice and research - Moye & Marson (2007) - Article

There are two ethical principles that dominate the field of capacity assessment. These principles are autonomy (self-determination) and protection (beneficence). What should a person do if his old relative who is frail and dementing begins to make decisions that put himself or herself or others in danger? At what point is a decision that is affected by a neuropsychiatric disease no longer a competent decision? This question is important in the clinical capacity assessment. The term ‘capacity’ is used to refer to a dichotomous (yes or no) judgment by a clinician as to whether a person can perform a specific task (driving independently) or make a specific decision (changing a will). There are eight major capacity domains or relevance to older adults with neuropsychiatric illness, some research think there might be even more. These eight are financial management, independent living, testamentary capacity, research consent, treatment consent, driving, voting and sexual consent. Independent living and general financial management require a broad set of cognitive and procedural skills. The other capacities are narrower in scope and they focus only on a small number of specific decisions. Decisions of capacity fall ultimately in legal judgment cases, but in practice most determinations of diminished capacity are made outside of the courtroom by attorneys, clinicians and protective service workers. An appointed surrogate (like a health care proxy) often has much to say about the capacity of the person. Many situations of diminished capacity are managed without a formal determination of incapacity or appointment of a surrogate. Somebody who is a caregiver to an adult with dementia may assume responsibility for bill paying or disallow driving. There is sometimes a fuzzy line between the family, the clinical role and judicial role in managing diminished capacities in older adults.

Changes and capacity assessment

Capacity assessment has become a topic of national concern. This is somewhat the result of sociodemographic changes. The population is ageing at a high pace and the prevalence of dementia, cognitive ageing and health issues increases largely with age. These physical and cognitive changes are linked with declines in everyday functioning. This includes loss of decision-making skills. Multiple medical conditions can effect decision-making abilities that vary across individuals. Some aspects of decision making are affected while others are not. We also have more attention to capacity issues as a result of large-scale cultural and financial changes. Because of this, courts see a rise in contested wills and guardianships and there is a higher prevalence of elder exploitation by friends and family. Because of these changes, capacity assessment has become an everyday issue that is stuck in different sectors of society. Many disciplines are involved with decision-making capacity and some of these include mental health workers, judges, police, biomedical clinicians, attorneys and relatives. Capacity determination is therefore a complex, cross-disciplinary things which involves knowledge of ethics, medical syndromes, the law and clinical assessment. Capacity assessment is researched by the legal, clinical and behavioural fields.

In the first part of the 20th century, incapacity was determined on the basis of the presence of a diagnosis alone. Sometimes also with the indication of mental status. Then there was a shift from diagnosis to the consideration of functional abilities relevant for specific capacity domains. With the emphasize on function, researchers tried to develop standardized instruments to measure skills in certain domains. For example, there are instruments to assess capacity to consent to treatment and research and instruments to assess financial decision making and to live independently. These assessment instruments try to improve upon the low reliability of more general clinical examinations. These instruments are meant to supplement the clinical judgment about the capacity. This means that a test score alone can’t substitute for a professional clinical judgment. It is difficult to develop an instrument, because there is no generally accepted criterion validity standard for capacity. Because of the development of standardized instruments, there came empirical capacity research. Research has focused on five core issues. Research has focused on the nature of capacity impairment within different groups, the reliability of capacity ratings across clinicians, the nature of capacity impairment within different patient groups, associations between different methods of capacity assessment and the longitudinal course of capacity change and decline.

Consent to medical treatment

Treatment consent capacity is important for personal autonomy. It refers to a patient’s emotional and cognitive capacity to select among treatment alternatives or to refuse a treatment. Consent capacity is important in the medical field and it requires that a valid consent to treatment be informed, voluntary and competent. Consent capacity is the ability to understand risks, benefits and alternatives to proposed health care and to make and talk about healthcare decisions. Treatment capacity is somewhat different than the other seven capacities mentioned at the beginning of this article, because it arises in a medical and not a legal setting and it involves a physician or psychologists and not a legal professional as decision maker about capacity. Also, these judgments are not subject to judicial review.

A US conceptual model of consent capacity outlines four core abilities:

  1. Expressing a choice

  2. Understanding: the ability to comprehend diagnostic and treatment information. Especially important in this is understanding the risks and the benefits of proposed treatments.

  3. Appreciation: the ability to relate treatment and diagnostic information to one’s own situation.

  4. Reasoning: the ability to rationally evaluate and compare different treatments.

The writers of this article reviewed 16 studies and they have found that older adults in long-term-care settings have high rates of capacity impairment. Also, older adults with dementia have also a reduced consent capacity. People with dementia are most impaired on measures of understanding, followed by reasoning and appreciation. There is also much agreement between physicians about the capacity. This is especially the case for dementia patients. There is not so much agreement between multiple capacity assessment methods. In some studies, the agreement between instrument-based assessment of capacity and physician-based assessment is poor, while in others it is good. The agreement is good for understanding, but poor for appreciation. In the articles, understanding was associated with conceptualization in Alzheimer’s Disease and executive functions, comprehensions and memory in people with Parkinson’s dementia. Appreciation is related to verbal fluency, visual attention and conceptualization in Alzheimer’s Disease, but no neuropsychological test was related to appreciation in Parkinson’s disease. Reasoning was related to executive functions, attention, memory and flexibility of memory in patients with Parkinson’s disease and with verbal fluency in Alzheimer’s disease. Auditory comprehension and expressing a choice are related in patients with Alzheimer’s disease and expressing a choice is related to memory, attention and executive functions in Parkinson’s disease. A factor study showed that neuropsychological factors predicted understanding, but they had modest to low prediction for the other three things.

Capacity to manage finances

Financial capacity is an important aspect of individual autonomy. Financial capacity differs from medical decision-making capacity, because it’s range is broad from pragmatic, conceptual and judgment abilities, while medical decision-making capacity is largely a verbally mediated capacity. Studies have shown that financial capacity is an advanced activity of daily living in older adults. This is also called an instrument activity of daily living. Instrumental activities of daily living are different from household activities of daily living, like shopping and preparing meals and basic activities of daily living, like dressing and walking. Financial abilities are broad and range from basic skills of counting coins to conducting transactions, balancing a check book and executing a will to higher level abilities of deciding on investments. Financial abilities vary across individuals and it depend on the person’s occupational history, socioeconomic status and overall financial experience.

Although financial capacity is important, there have only been a few working conceptual models of financial capacity. One model that combines clinical aspects and cognitive neuropsychological aspect contains three elements:

  1. Declarative knowledge: the ability to describe facts, concepts and events that relate to financial activities, like currencies and concepts like rate or loans.

  2. Procedural knowledge: the ability to carry out motor based, practical financial skills, like writing checks.

  3. Judgment: the ability to make financial decisions that are consistent with one’s self-interest. This is the case for everyday and new situations.

This model sees financial capacity at three levels: specific abilities, broader areas of activity and overall financial capacity. Only recently has empirical research in the area of financial capacity in older adults emerged. Research that has been conducted has shown that the financial skills of patients with Alzheimer’s Disease are impaired relative to healthy older people. People with mild Alzheimer’s Disease show a deficit in different complex financial abilities and in almost all financial activities. People with moderate Alzheimer’s Disease show a loss of both complex and simple financial abilities and they also show an severe impairment across all financial activity. Research has also found that people with other forms of dementia show impairments in their financial abilities.

Capacity assessment these days

Capacity assessment will become more and more important. This is because of the ageing society. And of course, we are interested in being able to discriminate between impaired and intact function in older adults. There is an increase in longevity, dementia, transfer of wealth between generations and blended families and this will make issues of capacity loss in older people a public policy concern. The past decade capacity assessment in aging as a field of study emerged, as well as promising capacity assessment instruments. There are certain key areas that need more attention. One of these is the assessment of capacity to live independently. This capacity is so broad, that it can include almost all areas of functioning. Another area that deserves and is getting more attention (because of blended families and transgenerational transfer of money) is testamentary capacity and the exploitation of older adults with diminished capacities. A new concept in this field is undue influence, which means that some form of coercion of a vulnerable adult to do something that will benefit the coercer. Sadly, there is an increase in the undue influence cases and there is very little literature or knowledge from the psychological field to draw upon. There are two other areas that are almost without study. These are sexual consent and voting capacity. Can people who have a cognitive impairment vote correctly and consent to having sex with somebody? More research is needed.

Looking at a wider range of capacities is not the only thing that is needed. Researchers should also look within a wider range of older patient groups. Studies should also focus on capacity impairment within dementia subtypes and also look at other neuropsychiatric illnesses, like schizophrenia and depression. Research should also look at capacity issues in developmental disorders, like autism and mental retardation. Studies should also look more into clinical decision making. We should know how clinical judgments of decisional capacity relate to the social dynamics of decision making. These studies should also look how clinicians from different disciplines may vary in their capacity assessment approach. Research should also look into identifying behavioural and cognitive markers of diminished capacity. There must be a solid empirical research base to ensure the accuracy and quality of capacity determination. The clinician’s opinion is currently the accepted clinical standard for capacity determination, but clinical judgments of capacity can be inaccurate, invalid or unreliable. Therefore, capacity assessment training should become a part of the clinical training of physicians, psychologists and other health care workers. Studies should also look at the relationship between legal and clinical models of capacity.

Access: 
Public
Access: 
Public

Image

Join WorldSupporter!
Search a summary

Image

 

 

Contributions: posts

Help other WorldSupporters with additions, improvements and tips

Add new contribution

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Image

Spotlight: topics

Check the related and most recent topics and summaries:
Activity abroad, study field of working area:

Image

Check how to use summaries on WorldSupporter.org

Online access to all summaries, study notes en practice exams

How and why use WorldSupporter.org for your summaries and study assistance?

  • For free use of many of the summaries and study aids provided or collected by your fellow students.
  • For free use of many of the lecture and study group notes, exam questions and practice questions.
  • For use of all exclusive summaries and study assistance for those who are member with JoHo WorldSupporter with online access
  • For compiling your own materials and contributions with relevant study help
  • For sharing and finding relevant and interesting summaries, documents, notes, blogs, tips, videos, discussions, activities, recipes, side jobs and more.

Using and finding summaries, notes and practice exams on JoHo WorldSupporter

There are several ways to navigate the large amount of summaries, study notes en practice exams on JoHo WorldSupporter.

  1. Use the summaries home pages for your study or field of study
  2. Use the check and search pages for summaries and study aids by field of study, subject or faculty
  3. Use and follow your (study) organization
    • by using your own student organization as a starting point, and continuing to follow it, easily discover which study materials are relevant to you
    • this option is only available through partner organizations
  4. Check or follow authors or other WorldSupporters
  5. Use the menu above each page to go to the main theme pages for summaries
    • Theme pages can be found for international studies as well as Dutch studies

Do you want to share your summaries with JoHo WorldSupporter and its visitors?

Quicklinks to fields of study for summaries and study assistance

Main summaries home pages:

Main study fields:

Main study fields NL:

Follow the author: Psychology Supporter
Work for WorldSupporter

Image

JoHo can really use your help!  Check out the various student jobs here that match your studies, improve your competencies, strengthen your CV and contribute to a more tolerant world

Working for JoHo as a student in Leyden

Parttime werken voor JoHo

Statistics
1997